GLENMARK PHARMACEUTICALS INC US
GLENMARK PHARMACEUTICALS INC US's Shipments Over Time
Purchase Ratings
Shipment Reliability and Frequency Volume of Goods
Avg. Shipments per Month: 8.80 Average TEU per month: 16.50
Active Months: 9 Average TEU per Shipment: 1.50
Shipment Frequency Std. Dev.: 10.19
Shipments By Companies
Company Name Shipments
GLENMARK PHARMACEUTICALS LTD 833 shipments
MANKIND PHARMA LTD 1 shipments
SANDOZ PRIVATE LIMITED 1 shipments
VKT PHARMA PRIVATE LIMITED 1 shipments
Shipments By HS Code
HS Code Shipments
300490 Medicaments; (not goods of heading no. 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic use, put up in measured doses (incl. those in the form of transdermal admin. systems) or packed for retail sale : Medicaments; consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale 77 shipments
652500 62 shipments
684620 57 shipments
662800 48 shipments
611600 Gloves, mittens and mitts; knitted or crocheted 47 shipments
624900 29 shipments
621000 Garments made up of fabrics of heading no. 5602, 5603, 5903, 5906 or 5907 (not knitted or crocheted) 25 shipments
642800 24 shipments
646700 22 shipments
652700 22 shipments
616900 21 shipments
210690 Food preparations not elsewhere specified or included : Food preparations; n.e.c. in item no. 2106.10 17 shipments
622200 17 shipments
271019 Petroleum oils and oils from bituminous minerals, not crude; preparations n.e.c, containing by weight 70% or more of petroleum oils or oils from bituminous minerals; these being the basic constituents of the preparations; waste oils : Petroleum oils and oils from bituminous minerals, not containing biodiesel, not crude, not waste oils; preparations n.e.c, containing by weight 70% or more of petroleum oils or oils from bituminous minerals; not light oils and preparations 16 shipments
652400 16 shipments
653900 16 shipments
611500 Hosiery; panty hose, tights, stockings, socks and other hosiery, including graduated compression hosiery (for example, stockings for varicose veins) and footwear without applied soles, knitted or crocheted 15 shipments
614000 14 shipments
614500 14 shipments
611300 Garments made up of knitted or crocheted fabrics of heading no. 5903, 5906 and 5907 : Garments made up of knitted or crocheted fabrics of heading no. 5903, 5906 and 5907 13 shipments
621300 Handkerchiefs (not knitted or crocheted) 13 shipments
620400 Suits, ensembles, jackets, dresses, skirts, divided skirts, trousers, bib and brace overalls, breeches and shorts (other than swimwear); women's or girls' (not knitted or crocheted) 11 shipments
642700 11 shipments
652600 11 shipments
651400 10 shipments
618100 9 shipments
290719 Phenols; monophenols, polyphenols, and phenol-alcohols : Monophenols; n.e.c. in item no. 2907.1 8 shipments
563100 8 shipments
642900 8 shipments
610400 Suits, ensembles, jackets, dresses, skirts, divided skirts, trousers, bib and brace overalls, breeches and shorts (not swimwear), women's or girls', knitted or crocheted 7 shipments
620600 Blouses, shirts and shirt-blouses; women's or girls' (not knitted or crocheted) 7 shipments
640800 7 shipments
300680 Pharmaceutical goods 6 shipments
613200 6 shipments
613700 6 shipments
621700 Clothing accessories n.e.c.; parts of garments or accessories other than those of heading no. 6212 (not knitted or crocheted) 6 shipments
621800 6 shipments
300449 Medicaments; (not goods of heading no. 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic use, put up in measured doses (incl. those in the form of transdermal admin. systems) or packed for retail sale : Medicaments; containing alkaloids or their derivatives; other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts; for therapeutic or prophylactic uses, packaged for retail sale 5 shipments
600700 5 shipments
612600 5 shipments
617200 5 shipments
620900 Garments and clothing accessories; babies' (not knitted or crocheted) 5 shipments
626800 5 shipments
646100 5 shipments
847439 Machinery for sorting, screening, separating, washing, crushing, grinding, mixing or kneading earth, stone, ores in solid form, shaping, moulding machinery for solid mineral fuels : Machines; for mixing or kneading mineral substances, excluding concrete mixers and machines for mixing mineral substances with bitumen 5 shipments
610300 Suits, ensembles, jackets, blazers, trousers, bib and brace overalls, breeches, shorts (not swimwear); men's or boys', knitted or crocheted 4 shipments
612800 4 shipments
621500 Ties, bow ties and cravats (not knitted or crocheted) 4 shipments
649900 4 shipments
609900 3 shipments
615500 3 shipments
619900 3 shipments
620200 Coats; women's or girls' overcoats, carcoats, capes, cloaks, anoraks, ski-jackets, wind-cheaters, wind-jackets and similar articles, other than those of heading no. 6204 (not knitted or crocheted) 3 shipments
620300 Suits, ensembles, jackets, blazers, trousers, bib and brace overalls, breeches and shorts (other than swimwear); men's or boys' (not knitted or crocheted) 3 shipments
646000 3 shipments
293299 Heterocyclic compounds with oxygen hetero-atom(s) only : Heterocyclic compounds; with oxygen hetero-atom(s) only, no lactones or unfused furan rings (hydrogenated or not) in the structure, other than isosafrole, 1-(1,3-benzodiaxol-5-yl) propan-2-one, piperonal, safrole, tetrahydrocannabinols (all isomers) 2 shipments
293399 Heterocyclic compounds with nitrogen hetero-atom(s) only : Heterocyclic compounds; n.e.c. in headings no. 2933 2 shipments
610200 Coats; women's or girls' overcoats, car-coats, capes, cloaks, anoraks, ski-jackets, wind-cheaters, wind-jackets and similar articles, knitted or crocheted, other than those of heading no. 6104 2 shipments
613800 2 shipments
614400 2 shipments
615100 2 shipments
624200 2 shipments
624400 2 shipments
625000 2 shipments
632500 2 shipments
632800 2 shipments
847480 Machinery for sorting, screening, separating, washing, crushing, grinding, mixing or kneading earth, stone, ores in solid form, shaping, moulding machinery for solid mineral fuels : Machines; for agglomerating, shaping or moulding solid mineral fuels, ceramic paste, unhardened cements, plastering materials in powder or paste form, machines for forming foundry moulds of sand 2 shipments
150100 Pig fat (including lard) and poultry fat, other than that of heading 0209 or 1503 1 shipments
170240 Sugars, including lactose, maltose, glucose or fructose in solid form; sugar syrups without added flavouring or colouring matter; artificial honey, whether or not mixed with natural honey; caramel : Sugars; glucose and glucose syrup, containing in the dry state at least 20% but less than 50% by weight of fructose, excluding invert sugar, the syrup not containing added flavouring or colouring matter 1 shipments
201500 1 shipments
210120 Extracts, essences, concentrates of coffee, tea or mate; preparations with a basis of these products or with a basis of coffee, tea or mate; roasted chicory and other roasted coffee substitutes and extracts, essences and concentrates thereof : Extracts, essences and concentrates; of tea or mate, and preparations with a basis of these extracts, essences or concentrates or with a basis of tea or mate 1 shipments
224900 1 shipments
256251 1 shipments
256253 1 shipments
292143 Amine-function compounds : Amine-function compounds; aromatic monoamines and their derivatives, toluidines and their derivatives; salts thereof 1 shipments
293379 Heterocyclic compounds with nitrogen hetero-atom(s) only : Heterocyclic compounds; lactams; other than 6-hexanelactam (epsilon caprolactam) and clobazam (INN) and methyprylon (INN) 1 shipments
326760 1 shipments
462978 1 shipments
551342 Woven fabrics of synthetic staple fibres, containing less than 85% by weight of such fibres, mixed mainly or solely with cotton, of a weight not exceeding 170g/m2 1 shipments
562000 1 shipments
609000 1 shipments
610900 T-shirts, singlets and other vests; knitted or crocheted 1 shipments
614300 1 shipments
621600 Gloves, mittens and mitts (not knitted or crocheted) : Gloves, mittens and mitts (not knitted or crocheted) 1 shipments
622900 1 shipments
623200 1 shipments
624000 1 shipments
624700 1 shipments
641200 1 shipments
647100 1 shipments
650121 Hat-forms, hat bodies and hoods of felt, neither blocked to shape nor with made brims; plateaux and manchons (including slit manchons) of felt 1 shipments
790190 Zinc; unwrought 1 shipments
870323 Motor cars and other motor vehicles; principally designed for the transport of persons (other than those of heading no. 8702), including station wagons and racing cars : Vehicles; with only spark-ignition internal combustion reciprocating piston engine, cylinder capacity over 1500 but not over 3000cc 1 shipments
to show market analysis.
Similar Companies
to see more.
Latest Shipments
Arrival Date Bill Of Lading Shipper Weight HS Code Description
2024-09-15 MAEU241955528 GLENMARK PHARMACEUTICALS LTD 10732.63 kg 300490 45 PALLETS 2141 CARTONS PH ARMACEUTICALS AS UNDER OLME SARTAN MEDOX TAB 20MG 30 NDC CODE:68462043730 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO .: 3004.90.9220 ANDA NO.: 20 3281 THERAPEUTICE USE: - -TR EATMENT OF HYPERTENSION, ALON E OR WITH OTHER ANTIHYPERTEN SIVE AGENTS, TO LOWER BLOOD P RESSURE GABAPENTIN TAB 600M G 500 NDC CODE:68462012605 F DA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE US E:-ANTICONVULSANT CICLOPIRO X OLAMINE CREAM 0.77% 90GM ND C CODE:68462029792 FDA PRODUC T CODE NO.:-61 W C J 03 H. T . S NO.: 3004.40.49.50 ANDA NO.:- 90 - 273 THERAPEUTICE USE:-ANTIFUNGAL USE. MUPIRO CIN OINT 2% 22GM NDC CODE:684 62018022 FDA PRODUCT CODE NO. : 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-48 0 THERAPEUTICE USE: - ANTI-B ACTERIAL COMMERCIAL & CUSTO M INVOICE NO. F22552001860 DT . 18.07.2024 F22552001861 DT. 18.07.2024 F22552001862 DT. 18.07.2024 F22552001859 DT. 1 8.07.2024 S/BILL NO: 2533039 DT 19-JUL-2024 S/BILL NO: 253 3035 DT 19-JUL-2024 S/BILL NO : 2533038 DT 19-JUL-2024 S/BI LL NO: 2533037 DT 19-JUL-2024 NET WT. 8859.238 KGS 02 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA
2024-09-15 MAEU242447310 GLENMARK PHARMACEUTICALS LTD 2950.21 kg 684620 12 PALLETS 1623 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 10MG 90 NDC CODE :68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE COMMERCIAL & CUSTOM INVOICE N O. F22552001797 DT. 15.07.202 4 S/BILL NO: 2433489 DT.15.07 .2024 NET WT. 2,266.77 KGS 1 2 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY P ARTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE D U PORT 2 NEUCHATEL - 2000 SW ITZERLAND
2024-09-15 MAEU241955524 GLENMARK PHARMACEUTICALS LTD 11037.45 kg 300490 43 PALLETS 2397 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 300MG 100 NDC C ODE:68462013801 FDA PRODUCT C ODE NO.:-61 M C A 45 HTS NO. 3004.90.9236 ANDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONV ULSANT AGENT OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:684620 39610 FDA PRODUCT CODE NO.:6 2KCF10 HTS NO.3004.90.9255 A NDA NO.:91672 THERAPEUTICE US E: -TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE GABAPENTIN TAB 800MG 500 NDC CODE:68462012705 FDA PRODUCT CODE:NO : 61 N C A 69 HTS N O.3004.90.9236 ANDA NO.:-77-6 62 THERAPEUTICE USE:-ANTICON VULSANT CICLOPIROX GEL 0.77 % 100GM NDC CODE:68462045594 FDA PRODUCT CODE NO.: 61WCJ4 3 H. T. S NO.: 3004.49.00.50 ANDA NO.: 091595 THERAPEUTI CE USE: - ANTIFUNGAL CLIND AMYCIN PHOS GEL 1% 30GM NDC C ODE:68462086635 FDA PRODUCT C ODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO. :214251 THERAPEUTICE USE: CL INDAMYCIN PHOSPHATE GEL IS IN DICATED IN THE TREATMENT OF A CNE VULGARIS CLINDAMYCIN P HOS GEL 1% 60GM NDC CODE:6846 2086665 FDA PRODUCT CODE NO.: 56 J D J 31 H. T. S NO.: 3 004.49.00.50 ANDA NO.:214251 THERAPEUTICE USE: CLINDAMYCI N PHOSPHATE GEL IS INDICATED IN THE TREATMENT OF ACNE VUL GARIS COMMERCIAL & CUSTOM INVOICE NO. F22552001834 DT. 17.07.2024 F22552001835 DT. 17.07.2024 F22552001837 DT. 1 7.07.2024 F22552001838 DT. 17 .07.2024 F22552001839 DT. 17. 07.2024 S/BILL NO: 2510601 DT 18-JUL-2024 S/BILL NO: 25106 08 DT 18-JUL-2024 S/BILL NO: 2510632 DT 18-JUL-2024 S/BILL NO: 2510603 DT 18-JUL-2024 S /BILL NO: 2510628 DT 18-JUL-20 24 NET WT. 9486.640 KGS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
2024-09-15 MAEU241955250 GLENMARK PHARMACEUTICALS LTD 8078.16 kg 300490 32 PALLETS 2440 CARTONS PH ARMACEUTICALS AS UNDER FLUC ONAZOLE TAB 200MG 30 NDC CODE :68462010430 FDA PRODUCT CODE NO : 61 W C A 45 H. T. S NO .: 3004.90.92.45 ANDA NO.:-7 7 - 253 THERAPEUTICE USE:-AN TIFUNGAL OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO .:91672 THERAPEUTICE USE: -T REATMENT OF TREAT GASTROESOPH AGEAL REFLUX DISEASE CICLO PIROX OLAMINE CREAM 0.77% 30GM NDC CODE:68462029735 FDA PR ODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40.49.50 A NDA NO.:- 90 - 273 THERAPEUTI CE USE:-ANTIFUNGAL USE. OM EPRAZOLE DR CAP 40MG 90 NDC C ODE:68462039790 FDA PRODUCT C ODE NO.:62KCF10 HTS NO.3004. 90.9255 ANDA NO.:91672 THERA PEUTICE USE: -TREATMENT OF TR EAT GASTROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F22552001798 DT. 15.07.2024 F22552001799 DT. 15.07.2024 F22552001803 DT. 1 5.07.2024 S/BILL NO: 2433485 DT: 15.07.2024 S/BILL NO: 243 3490 DT: 15.07.2024 S/BILL NO : 2439823DT: 15.07.2024 NET W T. 6454.948 KGS 02 DATA LOGG ERS SET TEMPERATURE : +18 D EGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
2024-07-23 MAEU241133493 GLENMARK PHARMACEUTICALS LTD 6173.5 kg 300490 42 PALLETS 1459 CARTONS PH ARMACEUTICALS AS UNDER FLUC ONAZOLE TAB 150MG 12UD NDC CO DE:68462011944 NDC CODE : 68 462011944 HTS NO : 3004.90.92 .45 FDA CODE : 61 W C A 45 A NDA NO. : 77 - 253 THERAPEUTI CE USE : ANTIFUNGAL OMEPRA ZOLE DR CAP 40MG 90 NDC CODE: 68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9 255 ANDA NO.:91672 THERAPEUT ICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISE ASE OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO.:916 72 THERAPEUTICE USE: -TREATM ENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUSTOM INVOICE NO. F225520 01180 DT. 12.06.2024 F2255200 1181 DT. 12.06.2024 S/BILL N O:1641662 DT 13-JUN-2024 S/BI LL NO:1641646 DT 13-JUN-2024 NET WT. 4814.363 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEM PERATURE : +18 DEGREES TEMPER ATURE RANGE : +15 DEGREES TO + 25 DEGREES NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 75 0, CORPORATE DRIVE, NEW JERSE Y MAHWAH - 07430 USA
2024-07-12 MAEU240200149 GLENMARK PHARMACEUTICALS LTD 11284.66 kg 300490 46 PALLETS 3105 CARTONS PH ARMACEUTICALS AS UNDER MUPI ROCIN CREAM 2% 30GM NDC CODE: 68462056435 FDA PRODUCT CODE NO.: 61GCJ82 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 201587 THERAPEUTICE USE: - TOPICAL ANTI-BACTERIAL ATOVAQUONE- PROG TAB 62.5/25MG 100 NDC CO DE:68462040201 FDA PRODUCT CO DE NO.: 62 L D A 44 H. T. S NO.: 3004.90.92.90 ANDA NO.: 91-211 ANTI MALARIAL TOPI RAMATE TAB 25MG 60 NDC CODE:6 8462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.:- 77 -627 THERAPEUTICE USE:-ANTIC ONVULSANT NAPROXEN TAB 500M G 100 NDC CODE:68462019001 F DA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-250 THERAPEU TICE USE:-ANTI-INFLAMMATORY, ANALGESIC NAPROXEN TAB 250 MG 100 NDC CODE:68462018801 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92 .40 ANDA NO.:-78-250 THERAPE UTICE USE:-ANTI-INFLAMMATORY, ANALGESIC NAPROXEN TAB 50 0MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAP EUTICE USE:-ANTI-INFLAMMATORY , ANALGESIC NAPROXEN TAB 5 00MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90. 92.40 ANDA NO.:-78-250 THERA PEUTICE USE:-ANTI-INFLAMMATOR Y, ANALGESIC OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:68462 039610 FDA PRODUCT CODE NO.: 62KCF10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE U SE: -TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE TOPIRAMATE TAB 50MG 60 NDC CODE:68462015360 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO .:- 77-627 THERAPEUTICE USE: -ANTICONVULSANT COMMERCIAL & CUSTOM INVOICE NO. F2255200 1030 DT. 31.05.2024 F22552000 961 DT. 31.05.2024 F225520009 93 DT. 31.05.2024 F2255200101 0 DT. 31.05.2024 F22552001048 DT. 31.05.2024 F22552001039 DT. 31.05.2024 F22552001042 D T. 31.05.2024 S/BILL NO: 1426 146 DT 04-JUN-2024 S/BILL NO: 1426563 DT 04-JUN-2024 S/BIL L NO: 1426562 DT 04-JUN-2024 S/BILL NO: 1426456 DT 04-JUN-2 024 S/BILL NO: 1426458 DT 04- JUN-2024 S/BILL NO: 1426341 D T 04-JUN-2024 S/BILL NO: 1426 332 DT 04-JUN-2024 NET WT:950 1.728 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RAN GE : +15 DEGREES TO +25 DEGREE S NOTIFY PARTY:2 GLENMARK PH ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
2024-07-12 MAEU240412713 GLENMARK PHARMACEUTICALS LTD 9689.8 kg 300490 45 PALLETS 1978 CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAP 40MG 1000 NDC C ODE:68462039710 FDA PRODUCT C ODE NO.:62KCF10 HTS NO.3004. 90.9255 ANDA NO.:91672 THERA PEUTICE USE: -TREATMENT OF TR EAT GASTROESOPHAGEAL REFLUX DISEASE TOPIRAMATE TAB 25MG 500 NDC CODE:68462010805 FD A PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.2 0 ANDA NO.:077627 THERAPEUTI CE USE: ANTICONVULSANT TOP IRAMATE TAB 25MG 500 NDC CODE :68462010805 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO .: 3004.49.00.20 ANDA NO.:07 7627 THERAPEUTICE USE: ANTIC ONVULSANT TOPIRAMATE TAB 25 MG 1000 NDC CODE:68462010810 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.0 0.20 ANDA NO.:- 77-627 THERA PEUTICE USE:-ANTICONVULSANT TOPIRAMATE TAB 100MG 60 NDC CODE:68462010960 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA N O.:- 77-627 THERAPEUTICE USE :-ANTICONVULSANT OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:68 462039610 FDA PRODUCT CODE N O.:62KCF10 HTS NO.3004.90.925 5 ANDA NO.:91672 THERAPEUTIC E USE: -TREATMENT OF TREAT G ASTROESOPHAGEAL REFLUX DISEAS E MUPIROCIN CREAM 2% 15GM NDC CODE:68462056417 FDA PROD UCT CODE NO.: 61GCJ82 H. T. S NO.: 3004.90.92.45 ANDA NO .: 201587 THERAPEUTICE USE: - TOPICAL ANTI-BACTERIAL MU PIROCIN OINT 2% 22GM NDC CODE :68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO .: 3004.90.92.45 ANDA NO.: 9 0-480 THERAPEUTICE USE: - AN TI-BACTERIAL MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 90-480 THERA PEUTICE USE: - ANTI-BACTERIAL COMMERCIAL & CUSTOM INVOIC E NO. F22552000892 DT. 29.05. 2024 F22552000938 DT. 30.05.2 024 F22552001038 DT. 31.05.20 24 F22552001016 DT. 31.05.202 4 F22552001017 DT. 31.05.2024 F22552001033 DT. 31.05.2024 S/BILL NO: 1361097 DT 01-JUN- 2024 S/BILL NO: 1361435 DT 01 -JUN-2024 S/BILL NO: 1365596 DT 01-JUN-2024 S/BILL NO: 136 1434 DT 01-JUN-2024 S/BILL NO : 1361106 DT 01-JUN-2024 S/BI LL NO: 1361105 DT 01-JUN-2024 NET WT. 7983.030 KGS 02 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA
2024-07-12 MAEU240520727 GLENMARK PHARMACEUTICALS LTD 9763.74 kg 300490 43 PALLETS 4061 CARTONS P HARMACEUTICALS AS UNDER OLM ESARTAN MEDOX TAB 20MG 30 NDC CODE:68462043730 FDA PRODUCT CODE NO.: 62CCA68 H. T. S N O.: 3004.90.9220 ANDA NO.: 2 03281 THERAPEUTICE USE: - -T REATMENT OF HYPERTENSION, ALO NE OR WITH OTHER ANTIHYPERTE NSIVE AGENTS, TO LOWER BLOOD PRESSURE VERAPAMIL HCL ER T AB 180MG 100 NDC CODE:6846202 9301 NDC NO.: 68462029301 FD A PRODUCT CODE NO.: 62 O C B 13 HTS NO.3004.90.9221 ANDA NO.: 090700 THERAPEUTICE USE: --ANGINA TELMISARTAN TAB 80MG 30 NDC CODE:68462020130 HTS NO : 3004.90.92.20 FDA C ODE : 62 O C A 09 ANDA NO.: 9 0032 THERAPEUTICE USE : INDI CATED FOR THE TREATMENT OF H YPERTENSION, TO LOWER BLOOD P RESSURE TOPIRAMATE TAB 100M G 60 NDC CODE:68462010960 FD A PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.2 0 ANDA NO.:- 77-627 THERAPEU TICE USE:-ANTICONVULSANT N APROXEN TAB 500MG 100 NDC COD E:68462019001 FDA PRODUCT COD E NO.:-62 G C A 49 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-ANT I-INFLAMMATORY, ANALGESIC TOPIRAMATE TAB 100MG 500 NDC CODE:68462010905 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO .: 77627 THERAPEUTICE USE: : #ANTICONVULSANT CLINDAMYCIN -BPO GEL JAR 1%/5% 50GM NDC C ODE:68462048627 FDA PRODUCT C ODE NO.: 56 J D J 31 H. T. S NO.: 3004.49.00.50 ANDA NO. : 209252 ANTIBIOTIC THAT STOP S THE GROWTH OF ACNE-CAUSING BACTERIA AS WELL AS REDUCE O IL PRODUCTION IN THE SKIN, HE LPING KEEP PORES OPEN ACYC LOVIR OINT 5% 15GM NDC CODE:6 8462074617 FDA PRODUCT CODE N O.: 62 V C J 18 H. T. S NO.: 3004.49.00.50 ANDA NO.: 205 510 THERAPEUTICE USE: - AN A NTIVIRAL MEDICINE USED TO TRE AT OR PREVENT INFECTIONS CAUS ED BY CERTAIN KINDS OF VIRUSE S. EXAMPLES OF THESE INFECTIO NS INCLUDE HERPES AND SHINGLE S COMMERCIAL & CUSTOM INV OICE NO. F22552001109 DT. 06. 06.2024 F22552001110 DT. 06.0 6.2024 F22552001114 DT. 07.06 .2024 F22552001115 DT. 07.06. 2024 F22552001116 DT. 07.06.2 024 F22552001117 DT. 07.06.20 24 NET WT. 7644.895 KGS 06 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA N OTIFY PARTY:3 GLENMARK SPECIA LTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2 000 SWITZERLAND
2024-07-12 MAEU240520733 GLENMARK PHARMACEUTICALS LTD 10435.07 kg 300490 46 PALLETS 3201 CARTONS PH ARMACEUTICALS AS UNDER ROPI NIROLE TAB 0.5MG 100 NDC CODE :68462025401 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TRE ATMENT OF PARKINSONISM TOP IRAMATE TAB 25MG 60 NDC CODE: 68462010860 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO. : 3004.49.00.20 ANDA NO.:- 7 7-627 THERAPEUTICE USE:-ANTI CONVULSANT ROPINIROLE TAB 1 MG 100 NDC CODE:68462025501 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92 .40 ANDA NO.:- 90-135 THERAP EUTICE USE:-TREATMENT OF PAR KINSONISM LEVOCETIRIZINE DI HY TAB 5MG 90 NDC CODE:684620 34690 FDA PRODUCT CODE NO.: 61 X C A 51 H. T. S NO.: 300 4.90.91.80 ANDA NO.:90385 TH ERAPEUTICE USE: TREATMENT OF CHRONIC IDIOPATHIC URTICARIA OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:68462039610 FDA PR ODUCT CODE NO.:62KCF10 HTS N O.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE LITHIUM CARB CAP 600MG 100 NDC CODE:68462 022201 FDA PRODUCT CODE NO.: -61 N C E 37 H. T. S NO.: 30 04.49.00.20 ANDA NO.:- 79 -13 9 THERAPEUTICE USE:-ANTIMANI C AGENT VERAPAMIL HCL ER TA B 180MG 100 NDC CODE:68462029 301 NDC NO.: 68462029301 FDA PRODUCT CODE NO.: 62 O C B 1 3 HTS NO.3004.90.9221 ANDA N O.: 090700 THERAPEUTICE USE: --ANGINA VERAPAMIL HCL ER TAB 180MG 500 NDC CODE:684620 29305 NDC NO.: 68462029305 F DA PRODUCT CODE NO.: 62 O C B 13 HTS NO.3004.90.9221 ANDA NO.: 090700 THERAPEUTICE USE : --ANGINA MUPIROCIN OINT 2% 22GM NDC CODE:68462018022 FDA PRODUCT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.9 2.45 ANDA NO.: 90-480 THERAP EUTICE USE: - ANTI-BACTERIAL COMMERCIAL & CUSTOM INVOICE NO. F22552001086 DT. 05.06.2 024 F22552001085 DT. 05.06.20 24 F22552001087 DT. 05.06.202 4 F22552001082 DT. 05.06.2024 S/BILL NO: 1480014 DT 06-JUN -2024 S/BILL NO: 1479656 DT 0 6-JUN-2024 S/BILL NO: 1479659 DT 06-JUN-2024 S/BILL NO: 14 79664 DT 06-JUN-2024 NET WT. 8552.560 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA
2024-07-12 MAEU240984974 GLENMARK PHARMACEUTICALS LTD 994.29 kg 611600 4 PALLETS 480 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 40MG 30 NDC CODE:6 8462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 0791 72 THERAPEUTICE USE: - TO TR EAT HIGH CHOLESTEROL AND RELA TED CONDITIONS, AND TO PREVEN T CARDIOVASCULAR DISEASE C OMMERCIAL & CUSTOM INVOICE NO. F22587000338 DT. 31.05.2024 S/BILL NO:4009345 DT: 05/06/2 024 NET WT. 729.61 KGS 04 D ATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TE MPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERL AND
2024-07-12 MAEU240520731 GLENMARK PHARMACEUTICALS LTD 7983.36 kg 300490 42 PALLETS 1659 CARTONS PH ARMACEUTICALS AS UNDER SEVE LAMER HCL TAB 400MG 360 NDC C ODE:68462044626 FDA PRODUCT C ODE NO.: 63 L D A 04 H. T. S NO.: 3004.90.92.60 ANDA NO. :204724 THERAPEUTICE USE:SEV ELAMER HYDROCHLORIDE TABLETS ARE A PHOSPHATE BINDER INDIC ATED FOR THE CONTROL OF SERUM PHOSPHORUS IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON DI ALYSIS CLINDAMYCIN HCL CAP 300MG 100 NDC CODE:6846201440 1 FDA PRODUCT CODE NO.:56 J C E 20 H. T. S NO.: 2941.90. 5000 ANDA NO.:216957 THERAPE UTICE USE: :#TREATMENT OF NUM EROUS INFECTIONS, INCLUDING B UT NOT LIMITED TO SEPTICEMI A,INTRAABDOMINAL INFECTIONS, LOWER RESPIRATORY INFECTIONS , GYNECOLOGICAL INFECTIONS, B ONE AND JOINT INFECTIONS, AND SKIN AND SKIN STRUCTURE INF ECTIONS NICARDIPINE HCL CAP 30MG 90 NDC CODE:68462012190 FDA PRODUCT CODE NO.: 62 O C E 48 H. T. S NO.: 3004.90. 9220 ANDA NO.: 216357 THERAP EUTICE USE: :#CARDIOVASCULAR AGENT CALCIUM CHANNEL BLOCKE R GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRO DUCT CODE:NO : 61 N C A 69 H TS NO.3004.90.9236 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT GABAPENTIN TAB 600MG 500 NDC CODE:6846201260 5 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT FLUPH ENAZINE HCL TAB 5MG 100 NDC C ODE:68462033701 FDA PRODUCT C ODE NO.: 66 N C A 99 H. T. S NO.: 3004.90.9235 ANDA NO.: 216350 THERAPEUTICE USE: :# ANTI-PSYCHOTIC TACROLIMUS O INT 0.1% 60GM NDC CODE:684620 53465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 300 4.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIMU S IS A TOPICAL IMMUNOSUPPRESS IVE OINTMENT USED FOR THE TR EATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 A NDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICA L IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF M ODERATE-TO-SEVERE ATOPIC DERM ATITIS (ECZEMA). TACROLIMU S OINTMENT 0.03% 30GM NDC COD E:68462088135 FDA PRODUCT COD E NO.:64 T C J 08 H. T. S NO .: 3004.49.0050 ANDA NO.:210 393 THERAPEUTICE USE: TOPICA L IMMUNOSUPPRESSIVE AGENT CHLORPROMAZINE HCL TAB 50MG 1 00 NDC CODE:68462086301 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDER S SUCH AS SCHIZOPHRENIA OR M ANIC-DEPRESSION IN ADULTS CHLORPROMAZINE HCL TAB 200MG 1 00 NDC CODE:68462086501 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDER S SUCH AS SCHIZOPHRENIA OR M ANIC-DEPRESSION IN ADULTS TACROLIMUS OINTMENT 0.03% 30GM NDC CODE:68462088135 FDA PR ODUCT CODE NO.:64 T C J 08 H . T. S NO.: 3004.49.0050 AND A NO.:210393 THERAPEUTICE USE : TOPICAL IMMUNOSUPPRESSIVE AGENT COMMERCIAL & CUSTOM INVOICE NO. F22587000349 DT. 31.05.2024 F22587000369 DT. 3 1.05.2024 F22587000373 DT. 31 .05.2024 F22587000356 DT. 31. 05.2024 F22587000348 DT. 31.0 5.2024 F22587000332 DT. 31.05 .2024 F22587000350 DT. 31.05. 2024 S/BILL NO: 4009343 DT:05 /06/2024 S/BILL NO: 4009352 D T:05/06/2024 S/BILL NO: 40093 49 DT:05/06/2024 S/BILL NO:40 09351 DT:05/06/2024 S/BILL NO : 4009346 DT:05/06/2024 S/BIL L NO: 4009347 DT:05/06/2024 S /BILL NO: 4009350 DT:05/06/202 4 NET WT. 4480.113 KGS 02 D ATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TE MPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA
2024-05-20 MAEU237959456 GLENMARK PHARMACEUTICALS LTD 5765.26 kg 642900 41 PALLETS 1979 CARTONS PH ARMACEUTICALS AS UNDER LEVO NORGESTREL/EE TAB 0.09/0.02MG 84 NDC CODE:68462063729 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO.: 202791 THERAPEUTICE USE: - : USED FOR PREVENTING PREGNANCY NORETH ACE/EE T AB 1/0.02MG 63 NDC CODE:68462 013281 FDA PRODUCT CODE NO.: 65 J C A 25 H. T. S NO.: 300 6.60.00.00 ANDA NO.:206969 T HERAPEUTICE USE: - SECONDARY AMENORRHEA,ENDOMETRIOS IS AN D ABNORMAL UTERINE BLEEDING NORETH ACE/EE TAB 0.5MG/2.5M CG 84 NDC CODE:68462065629 F DA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00. 00 ANDA NO.: 203038 THERAPEU TICE USE: - TREATMENT OF MODE RATE TO SEVERE VASOMOTOR SYM PTOMS DUE TO MENOPAUSE; OSTE OPOROSIS PREVENTION COMMERC IAL & CUSTOM INVOICE NO. F225 52000047 DT. 06.04.2024 S/BIL L NO: 8975026 DT 08-APR-2024 NET WT.4,184.73 02 DATA LOGG ERS SET TEMPERATURE : +20 D EGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
2024-05-14 MAEU237097266 GLENMARK PHARMACEUTICALS LTD 7728.89 kg 300490 44 PALLETS 2075 CARTONS PH ARMACEUTICALS AS UNDER DROS PIRENONE/EE TAB 3/0.03MG 84 N DC CODE:68462073329 FDA PRODU CT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204848 THERAPEUTICE USE : - CONTRACEPTION TO PREVENT PREGNANCY ESTRADIOL VAG IN SERTS 10MCG 8 NDC CODE:684620 71171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 300 6.60.00.00 ANDA NO.:210264 T HERAPEUTICE USE:THE TREATMENT OF ATROPIC VAGINITIS DUE TO MENOPAUSE. TELMISARTAN TAB 80MG 90 NDC CODE:68462020190 NDC NO.: 68462020190 FDA PR ODUCT CODE NO :62 O C A 09 H TS NO : 3004.90.92.20 ANDA NO .90032 THERAPEUTICE USE:-IND ICATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE NAPROXEN TAB 500MG 100 NDC CODE:68462019001 FD A PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.4 0 ANDA NO.:-78-250 THERAPEUT ICE USE:-ANTI-INFLAMMATORY, ANALGESIC NAPROXEN TAB 500M G 500 NDC CODE:68462019005 F DA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-250 THERAPEU TICE USE:-ANTI-INFLAMMATORY, ANALGESIC OMEPRAZOLE DR CA P 40MG 1000 NDC CODE:68462039 710 FDA PRODUCT CODE NO.:62K CF10 HTS NO.3004.90.9255 AND A NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GASTROE SOPHAGEAL REFLUX DISEASE O MEPRAZOLE DR CAP 20MG 1000 ND C CODE:68462039610 FDA PRODUC T CODE NO.:62KCF10 HTS NO.30 04.90.9255 ANDA NO.:91672 TH ERAPEUTICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REFLU X DISEASE ONDANSETRON ODT 8MG 30UD NDC CODE:68462015813 FDA PRODUCT CODE.:-61 T C A 26 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-152 THERAPEU TICE USE:-ANTI -EMETIC COM MERCIAL & CUSTOM INVOICE NO. F22452006425 DT. 29.03.2024 F 22452006434 DT. 29.03.2024 F2 2452006394 DT. 27.03.2024 F22 452006441 DT. 29.03.2024 F224 52006442 DT. 29.03.2024 S/BIL L NO: 8770843 DT 30-MAR-2024 S/BILL NO: 8763127 DT 30-MAR-2 024 S/BILL NO: 8763117 DT. 30 -MAR-2024 S/BILL NO: 8763135 DT 30-MAR-2024 S/BILL NO: 876 3126 DT 30-MAR-2024 NET WT. 6 208.81 KGS 02 DATA LOGGERS H UMIDITY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHA RMACEUTICALS INC 750, CORPORA TE DRIVE, NEW JERSEY MAHWAH - 07430 USA
2024-05-14 MAEU237894541 GLENMARK PHARMACEUTICALS LTD 11944.65 kg 300490 46 PALLETS 4011 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 3.125MG 500 NDC CO DE:68462016205 FDA PRODUCT CO DE NO :62 O C A 22 HTS NO.30 04.90.9221 ANDA NO.78-251 TH ERAPEUTICE USE:-BETA- ADRENO ACEPTOR ANTAGONIST TELMISA RTAN TAB 80MG 30 NDC CODE:684 62020130 HTS NO : 3004.90.92. 20 FDA CODE : 62 O C A 09 AN DA NO.: 90032 THERAPEUTICE US E : INDICATED FOR THE TREATM ENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE ZOLMITRIPT AN TAB 2.5MG 6UD NDC CODE:684 62049776 FDA PRODUCT CODE NO. : 60 L C A 90 H. T. S NO.: 3004.90.92.28 ANDA NO.: 20177 9 THERAPEUTICE USE: - ANALGE SIC/ HUMAN - RX/SINGLE INGRED IENT / PROMPT RELEASE TABLET S / ZOLMITRIPTAN (ANALGESIC) OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PROD UCT CODE NO.:62KCF10 HTS NO. 3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REF LUX DISEASE ROPINIROLE TAB 1MG 100 NDC CODE:68462025501 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90. 92.40 ANDA NO.:- 90-135 THER APEUTICE USE:-TREATMENT OF P ARKINSONISM GABAPENTIN TAB 800MG 500 NDC CODE:6846201270 5 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT GABAP ENTIN TAB 800MG 500 NDC CODE: 68462012705 FDA PRODUCT CODE :NO : 61 N C A 69 HTS NO.3004 .90.9236 ANDA NO.:-77-662 TH ERAPEUTICE USE:-ANTICONVULSAN T ACYCLOVIR OINT 5% 30GM N DC CODE:68462074635 FDA PRODU CT CODE NO.: 62 V C J 18 H. T. S NO.: 3004.49.00.50 ANDA NO.: 205510 THERAPEUTICE USE : - AN ANTIVIRAL MEDICINE USE D TO TREAT OR PREVENT INFECTI ONS CAUSED BY CERTAIN KINDS OF VIRUSES. EXAMPLES OF THESE INFECTIONS INCLUDE HERPES AN D SHINGLES ROSUVASTATIN TAB 40MG 30 NDC CODE:68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.0 0.10 ANDA NO.: 079172 THERAP EUTICE USE: - TO TREAT HIGH C HOLESTEROL AND RELATED CONDIT IONS, AND TO PREVENT CARDIOV ASCULAR DISEASE ROSUVASTATI N TAB 40MG 500 NDC CODE:68462 026405 61 J C A 16 3004.49.0 0.10 79172 TO TREAT HIGH CHO LESTEROL AND RELATED CONDITIO NS, AND TO PREVENT CARDIOVAS CULAR DISEASE COMMERCIAL & CUSTOM INVOICE NO. F224520064 95 DT. 31.03.2024 F2255200001 5 DT. 04.04.2024 F22552000016 DT. 04.04.2024 F22552000017 DT. 04.04.2024 F22552000023 D T. 04.04.2024 F22552000018 DT . 04.04.2024 F22552000024 DT. 04.04.2024 F22552000026 DT. 04.04.2024 S/BILL NO: 8904425 DT:04042024 S/BILL NO: 89044 27 DT:04042024 S/BILL NO: 890 4426 DT:04042024 S/BILL NO: 8 904429 DT:04042024 S/BILL NO: 8904438 DT:04042024 S/BILL N O: 8904424 DT:04042024 S/BILL NO: 8904432 DT:04042024 S/BI LL NO: 8904431 DT:04042024 NE T WT. 9970.203 KGS 09 DATA L OGGERS SET TEMPERATURE : +2 0 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA NOTIF Y PARTY:3 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLAC E DU PORT 2 NEUCHATEL - 2000 SWITZERLAND
2024-05-14 MAEU237959461 GLENMARK PHARMACEUTICALS LTD 6467.88 kg 300490 26 PALLETS 1504 CARTONS PH ARMACEUTICALS AS UNDER TACR OLIMUS OINT 0.1% 100GM NDC CO DE:68462053494 FDA PRODUCT CO DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). CLINDAMYCIN HCL C AP 150MG 100 NDC CODE:6846201 4301 FDA PRODUCT CODE NO.:56 J C E 20 H. T. S NO.: 2941. 90.5000 ANDA NO.:216957 THER APEUTICE USE: :#TREATMENT OF NUMEROUS INFECTIONS, INCLUDIN G BUT NOT LIMITED TO SEPTIC EMIA,INTRAABDOMINAL INFECTION S, LOWER RESPIRATORY INFECTI ONS, GYNECOLOGICAL INFECTIONS , BONE AND JOINT INFECTIONS, AND SKIN AND SKIN STRUCTURE INFECTIONS POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:684620 35701 FDA PRODUCT CODE NO.:6 5 R C F 14 H. T. S NO.: 3004 .90.92.90 ANDA NO.:202868 TH ERAPEUTICE USE: - TREATMENT O R PREVENTION OF HYPOKALEMIA GABAPENTIN TAB 600MG 500 N DC CODE:68462012605 FDA PRODU CT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC ONVULSANT GABAPENTIN TAB 60 0MG 500 NDC CODE:68462012605 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT EZETIMI BE TAB 10MG 500 NDC CODE:6846 2022605 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3 004.49.00.10 ANDA NO.: #07856 0 THERAPEUTICE USE: LIPID LO WERING AGENT GABAPENTIN TAB 600MG 500 NDC CODE:684620126 05 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTIC E USE:-ANTICONVULSANT COMM ERCIAL & CUSTOM INVOICE NO. F 22487002437 DT. 31.03.2024 F2 2487002440 DT. 31.03.2024 F22 487002441 DT. 31.03.2024 F224 87002446 DT. 31.03.2024 F2248 7002447 DT. 31.03.2024 F22487 002449 DT. 31.03.2024 S/BILL NO: 4005655 DT: 02/04/2024 S/ BILL NO: 4005654 DT: 02/04/202 4 S/BILL NO: 4005653 DT: 02/0 4/2024 S/BILL NO: 4005652 DT: 02/04/2024 S/BILL NO: 400565 0 DT: 02/04/2024 S/BILL NO: 4 005649 DT: 02/04/2024 NET WT. 4339.144 KGS DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA
2024-05-14 MAEU238282185 VKT PHARMA PRIVATE LIMITED 3099.45 kg 300490 15 PALLETS 2404 CARTONS PHAR MACEUTICALS AS UNDER FAMOTIDI NE TABLETS, USP 10MG NDC NO.7 2657011220 FDA PRODUCT CODE: 60 S A A 22 HTS CODE: 3004.9 0.92.55 ANDA NO. 215822 FAMO TIDINE TABLETS, USP 20MG NDC NO. 72657011320 FDA PRODUCT C ODE:60 S A A 22 HTS CODE: 300 4.90.92.55 ANDA NO. 215822 C OMMERCIAL & CUSTOM INVOICE NO. VKT/EX/045/23-24 DT. 30.03.2 024 S/BILL NO: 8890444 DT:04/ 04/2024 NET WT: 2137.800 KGS 3 DATA LOGGERS SET TEMPERA TURE : +20 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA
2024-05-07 MAEU237096552 GLENMARK PHARMACEUTICALS LTD 6175.31 kg 611600 26 PALLETS 3051 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 5MG 90 NDC CODE: 68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079 172 THERAPEUTICE USE: - TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA N O.: 79172 THERAPEUTICE USE: T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO P REVENT CARDIOVASCULAR DISEASE . ROSUVASTATIN TAB 40MG 500 NDC CODE:68462026405 61 J C A 16 3004.49.00.10 79172 T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PR EVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 40MG 30 N DC CODE:68462026430 FDA PRODU CT CODE NO.:61 J C A 16 H. T . S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DIS EASE ROSUVASTATIN TAB 5MG 1 000 NDC CODE:68462026110 FDA PRODUCT CODE NO.: 61 J C A 1 6 H. T. S NO.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTIC E USE: TO TREAT HIGH CHOLESTE ROL AND RELATED CONDITIONS, A ND TO PREVENT CARDIOVASCULAR DISEASE. COMMERCIAL & CUST OM INVOICE NO. F22452006291 D T. 22.03.2024 F22452006292 DT . 22.03.2024 S/BILL NO: 85873 72 DT 23-MAR-2024 S/BILL NO: 8587363 DT 23-MAR-2024 NET WT .4,880.88 KGS 26 DATA LOGGER S SET TEMPERATURE : +20 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUC HATEL - 2000 SWITZERLAND
2024-05-07 MAEU237097259 GLENMARK PHARMACEUTICALS LTD 7426.79 kg 300490 39 PALLETS 2365 CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAP 20MG 1000 NDC C ODE:68462039610 FDA PRODUCT C ODE NO.:62KCF10 HTS NO.3004. 90.9255 ANDA NO.:91672 THERA PEUTICE USE: -TREATMENT OF TR EAT GASTROESOPHAGEAL REFLUX DISEASE OMEPRAZOLE DR CAP 4 0MG 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO. :91672 THERAPEUTICE USE: -TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE ONDANS ETRON ODT 8MG 30UD NDC CODE:6 8462015813 FDA PRODUCT CODE.: -61 T C A 26 H. T. S NO.: 3 004.90.92.40 ANDA NO.:-78-152 THERAPEUTICE USE:-ANTI -EME TIC TROSPIUM CL TAB 20MG 60 NDC CODE:68462046160 FDA PR ODUCT CODE NO.:-61 K C A 69 H. T. S NO.: 3004.49.00.70 A NDA NO.:-91-575 THERAPEUTICE USE:- TREATMENT OF VENOUS DI SEASES URINARY INCONTINENCE THERAPY GABAPENTIN TAB 600M G 500 NDC CODE:68462012605 F DA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE US E:-ANTICONVULSANT MARLISSA TAB 0.15/0.03MG 84 NDC CODE:6 8462038829 FDA PRODUCT CODE N O.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO.: 0914 52 THERAPEUTICE USE: ORAL CO NTRACEPTIVE COMMERCIAL & CU STOM INVOICE NO. F22452006327 DT. 24.03.2024 F22452006328 DT. 24.03.2024 F22452006310 D T. 23.03.2024 S/BILL NO: 8615 589 DT 25-MAR-2024 S/BILL NO: 8615426 DT 25-MAR-2024 S/BIL L NO: 8615425 DT 25-MAR-2024 NET WT.5979.660 KGS 02 DATA LOGGERS SET TEMPERATURE : + 20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA
2024-05-07 MAEU237852666 GLENMARK PHARMACEUTICALS LTD 5019.08 kg 210690 CARGO DESCRIPTION, HS CODE AN D AGENT ADDRESS. 23 PALLETS 1861 CARTONS PHARMACEUTICALS AS UNDER OXCARBAZEPINE TAB 30 0MG 100 NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 HTS NO.3004.90.9236 AN DA NO.:-77-802 THERAPEUTICE U SE:-ANTI CONVULSANT AGENT ON DANSETRON ODT 8MG 10UD NDC CO DE:68462015811 FDA PRODUCT CO DE NO.:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.: -78-152 THERAPEUTICE USE:-ANT I -EMETIC TROSPIUM CL TAB 20 MG 60 NDC CODE:68462046160 F DA PRODUCT CODE NO.:-61 K C A 69 H. T. S NO.: 3004.49.00. 70 ANDA NO.:-91-575 THERAPEU TICE USE:- TREATMENT OF VENOU S DISEASES URINARY INCONTINE NCE THERAPY OXCARBAZEPINE TA B 300MG 100 NDC CODE:68462013 801 FDA PRODUCT CODE NO.:-61 M C A 45 HTS NO.3004.90.9236 ANDA NO.:-77-802 THERAPEUTI CE USE:-ANTI CONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22452006290 DT. 22.03.20 24 F22452006293 DT. 23.03.202 4 S/BILL NO: 8587864 DT 23-MA R-2024 S/BILL NO: 8587491 DT 23-MAR-2024 NET WT.3971.970 K GS 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA CLAUSES - NEW AGENT AT DESTINATION: MAERSK INC. 2 G IRALDA FARMS MADISON AVENUE P.O. BOX 880 07940-0880 MADI SON, NJ USA PHONE: CUSTOMER SERVICE 1 (800) 321-8807 GIR ALDA FARMS (NY/NJ) 1 (973) 514 -5000 BALTIMORE 1 (800) 854-6 553 BOSTON 1 (800) 854-6553 PHILADELPHIA 1 (800) 854-6553 ROCHESTER 1 (800) 854-6553 F AX: GIRALDA FARMS (NY/NJ) 1 ( 973) 514-5410 BALTIMORE 1 (88 8) 249-8016 BOSTON 1 (866) 34 5-8986 PHILADELPHIA 1 (888) 2 49-8016
2024-05-07 MAEU237097256 GLENMARK PHARMACEUTICALS LTD 9860.36 kg 300490 44 PALLETS 1900 CARTONS PH ARMACEUTICALS AS UNDER VIOR ELE TAB 0.15/0.02-0.01MG 84 N DC CODE:68462031829 FDA PRODU CT CODE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 ANDA NO.: 091346 THERAPEUTICE USE : - ORAL CONTRACEPTIVES NO RETH ACE/EE TAB 1MG/5MCG 90 N DC CODE:68462065790 FDA PRODU CT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE : - TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS D UE TO MENOPAUSE; OSTEOPOROSIS PREVENTION NAPROXEN TAB 50 0MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:-78-250 THERAP EUTICE USE:-ANTI-INFLAMMATORY , ANALGESIC GABAPENTIN TAB 800MG 500 NDC CODE:684620127 05 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTIC E USE:-ANTICONVULSANT GABA PENTIN TAB 800MG 500 NDC CODE :68462012705 FDA PRODUCT COD E:NO : 61 N C A 69 HTS NO.300 4.90.9236 ANDA NO.:-77-662 T HERAPEUTICE USE:-ANTICONVULSA NT COMMERCIAL & CUSTOM INVO ICE NO. F22452006392 DT. 27.0 3.2024 F22452006371 DT. 27.03 .2024 F22452006373 DT. 27.03. 2024 F22452006384 DT. 27.03.2 024 S/BILL NO: 8700101 DT 28- MAR-2024 S/BILL NO: 8700874 D T 28-MAR-2024 S/BILL NO: 8714 651 DT 28-MAR-2024 S/BILL NO: 8715794 DT 28-MAR-2024 NET W T. 8283.895 KGS 02 DATA LOG GERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
2024-05-07 MAEU237096991 GLENMARK PHARMACEUTICALS LTD 11071.02 kg 300490 43 PALLETS 4062 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 40MG 30 NDC CODE :68462026430 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO. : 3004.49.00.10 ANDA NO.: 07 9172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RE LATED CONDITIONS, AND TO PREV ENT CARDIOVASCULAR DISEASE CARVEDILOL TAB 12.5MG 500 ND C CODE:68462016405 FDA PRODUC T CODE NO :62 O C A 22 HTS N O.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST CAR VEDILOL TAB 12.5MG 500 NDC CO DE:68462016405 FDA PRODUCT CO DE NO :62 O C A 22 HTS NO.30 04.90.9221 ANDA NO.78-251 TH ERAPEUTICE USE:-BETA- ADRENO ACEPTOR ANTAGONIST CARVEDI LOL TAB 25MG 500 NDC CODE:684 62016505 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90. 9221 ANDA NO.78-251 THERAPEU TICE USE:-BETA- ADRENOACEPTO R ANTAGONIST PIMECROLIMUS CREAM 1% 60GM NDC CODE:684620 60965 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 300 4.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECOUN D-LINE THERAPY FOR THE SHORT- TERM AND NON-CONTINUOS CHRONI C TRERTMENT OF MILD TO MODER ATE ATOPIC DERMATITIS IN NON - IMMUNOCOMPROMISED ADULT AN D CHILDREN 2 YEARS OF AGE SIROLIMUS TAB 0.5MG 100 NDC C ODE:68462068201 FDA PRODUCT C ODE NO.: 64 T C A 12 H. T. S NO.: 3004.90.92.15 ANDA NO. : 208691 THERAPEUTICE USE: TO PREVENT REJECTION OF KIDNEY TRANSPLANTS. SIROLIMUS TAB 2MG 100 NDC CODE:68462068401 FDA PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90. 92.15 ANDA NO.: 208691 THERA PEUTICE USE: TO PREVENT REJEC TION OF KIDNEY TRANSPLANTS. COMMERCIAL & CUSTOM INVOICE NO. F22487002384 DT. 27.03.20 24 F22487002385 DT. 27.03.202 4 F22487002386 DT. 27.03.2024 F22487002387 DT. 27.03.2024 F22487002388 DT. 27.03.2024 S/BILL NO: 4005206 DT:28/03/20 24 S/BILL NO: 4005203 DT:28/0 3/2024 S/BILL NO: 4005205 DT: 28/03/2024 S/BILL NO: 4005202 DT:28/03/2024 S/BILL NO: 400 5204 DT:28/03/2024 NET WT. 84 09.173 KGS 18 DATA LOGGERS SET TEMPERATURE : +20 DEGREE S NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA NOTIFY PARTY: 3 GLENMARK SPECIALTY S.A. SW ITZERLAND (GSSA) PLACE DU POR T 2 NEUCHATEL - 2000 SWITZER LAND
2024-05-07 MAEU237097264 GLENMARK PHARMACEUTICALS LTD 6195.27 kg 642800 40 PALLETS 2400 CARTONS PH ARMACEUTICALS AS UNDER ESTR ADIOL VAG INSERTS 10MCG 8 NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA N O.:210264 THERAPEUTICE USE:TH E TREATMENT OF ATROPIC VAGIN ITIS DUE TO MENOPAUSE. COM MERCIAL & CUSTOM INVOICE NO. F22452006404 DT. 28.03.2024 S /BILL NO: 8715790 DT 28-MAR-20 24 NET WT. 4665.600 KGS 02 D ATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
2024-05-07 MAEU237097260 GLENMARK PHARMACEUTICALS LTD 11115.47 kg 300490 44 PALLETS 3062 CARTONS PH ARMACEUTICALS AS UNDER TELM ISARTAN TAB 80MG 30 NDC CODE: 68462020130 HTS NO : 3004.90. 92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERAPEUTICE USE : INDICATED FOR THE TRE ATMENT OF HYPERTENSION, TO LO WER BLOOD PRESSURE ATOMOXE TINE CAP 100MG 30 NDC CODE:68 462027130 FDA PRODUCT CODE NO .: 64 UCA 99 H. T. S NO.: 3 004.90.92.90 ANDA NO.: 079019 TREATMENT OF ATTENTION - DE FICIT/HYPERACIVITY DISORDER ( ADHD NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PR ODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 A NDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAMMATORY, ANAL GESIC FELODIPINE ER TAB 2.5 MG 100 NDC CODE:68462023301 FDA PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-365 THERAPEUTIC E USE: - TREATMENT OF HYPERT ENSION GABAPENTIN TAB 800MG 500 NDC CODE:68462012705 FD A PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE USE :-ANTICONVULSANT OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:68 462039710 FDA PRODUCT CODE N O.:62KCF10 HTS NO.3004.90.925 5 ANDA NO.:91672 THERAPEUTIC E USE: -TREATMENT OF TREAT G ASTROESOPHAGEAL REFLUX DISEAS E ROSUVASTATIN TAB 20MG 90 NDC CODE:68462026390 FDA PRO DUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 AND A NO.: 079172 THERAPEUTICE US E: - TO TREAT HIGH CHOLESTERO L AND RELATED CONDITIONS, AN D TO PREVENT CARDIOVASCULAR D ISEASE CARVEDILOL TAB 6.25M G 500 NDC CODE:68462016305 F DA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST AC RLF ADAPALENE GEL 0.1 % 45GM (CURIST) NDC CODE:7255 9001513 FDA PRODUCT CODE NO.: 62 S C J 02 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 208108 THERAPEUTICE USE: #TOPICAL ANTI-ACNE AGENT COMMERCIAL & CUSTOM INVOICE NO. F2245200 6396 DT. 27.03.2024 F22452006 395 DT. 27.03.2024 F224520063 86 DT. 27.03.2024 F2245200641 3 DT. 28.03.2024 F22452006410 DT. 28.03.2024 F22452006412 DT. 28.03.2024 F22452006401 D T. 28.03.2024 S/BILL NO: 8717 970 DT 28-MAR-2024 S/BILL NO: 8718032 DT 28-MAR-2024 S/BIL L NO: 8717979 DT 28-MAR-2024 S/BILL NO: 8718030 DT 28-MAR-2 024 S/BILL NO: 8718031 DT 28- MAR-2024 S/BILL NO: 8717940 D T 28-MAR-2024 S/BILL NO: 8717 939 DT 28-MAR-2024 NET WT. 94 10.872 KGS 09 DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERL AND NOTIFY PARTY:4 CURIST C/ O BAKER INDUSTRIES 184 PENNSY LVANIA AVE PENNSYLVANIA MALV ERN USA- 19355 LABELER CODE : 68462:
2024-05-07 MAEU237852207 GLENMARK PHARMACEUTICALS LTD 332.49 kg 271019 2 PALLETS 60 CARTONS PHARM ACEUTICALS AS UNDER ROSUVAS TATIN TAB 40MG 500 NDC CODE:6 8462026405 61 J C A 16 3004. 49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED COND ITIONS, AND TO PREVENT CARDI OVASCULAR DISEASE COMMERCIA L & CUSTOM INVOICE NO. F22452 006329 DT. 24.03.2024 S/BILL NO: 8615583 DT 25-MAR-2024 NE T WT.295.49 KGS 02 DATA LOGGE RS SET TEMPERATURE : +20 DE GREES NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. SWITZERLAN D (GSSA) PLACE DU PORT 2 NEU CHATEL - 2000 SWITZERLAND
2024-03-08 MAEU235518711 GLENMARK PHARMACEUTICALS LTD 13212.46 kg 300490 48 PALLETS 2583 CARTONS PHAR MACEUTICALS AS UNDER OMEPRAZO LE DR CAP 40MG 1000 NDC CODE: 68462039710 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9 255 ANDA NO.:91672 THERAPEUT ICE USE: -TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISE ASE OXCARBAZEPINE TAB 150MG 1 00 NDC CODE:68462013701 FDA PRODUCT CODE NO.:-61 M C A 45 HTS NO.3004.90.9236 ANDA NO .:-77-802 THERAPEUTICE USE:-A NTI CONVULSANT AGENT GABAPEN TIN TAB 600MG 500 NDC CODE:68 462012605 FDA PRODUCT CODE:N O : 61 N C A 69 HTS NO.3004.9 0.9236 ANDA NO.:-77-662 THER APEUTICE USE:-ANTICONVULSANT MUPIROCIN CREAM 2% 30GM NDC CODE:68462056435 FDA PRODUCT CODE NO.: 61GCJ82 H. T. S NO .: 3004.90.92.45 ANDA NO.: 2 01587 THERAPEUTICE USE: - TO PICAL ANTI-BACTERIAL GABAPENT IN TAB 600MG 500 NDC CODE:684 62012605 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90 .9236 ANDA NO.:-77-662 THERA PEUTICE USE:-ANTICONVULSANT COMMERCIAL & CUSTOM INVOICE NO . F22452005244 DT. 30.01.2024 F22452005245 DT. 30.01.2024 F22452005240 DT. 30.01.2024 F22452005252 DT. 30.01.2024 S /BILL NO:7132591 DT 30-JAN-202 4 S/BILL NO:7132642 DT 30-JAN -2024 S/BILL NO:7132594 DT 30 -JAN-2024 S/BILL NO:7132859 D T 30-JAN-2024 NET WT. 11,554. 77 KGS 02 DATA LOGGERS SET T EMPERATURE : +20 DEGREES TEMP ERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA
2024-03-08 MAEU235518720 GLENMARK PHARMACEUTICALS LTD 8317.66 kg 300490 40 PALLETS 2353 CARTONS PH ARMACEUTICALS AS UNDER PRAM IPEXOLE TAB 0.5MG 90 NDC CODE :68462033290 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO .: 3004.90.92.40 ANDA NO.: 9 0-781 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE OME PRAZOLE DR CAP 40MG 1000 NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004 .90.9255 ANDA NO.:91672 THER APEUTICE USE: -TREATMENT OF T REAT GASTROESOPHAGEAL REFLUX DISEASE TOPIRAMATE TAB 25M G 500 NDC CODE:68462010805 F DA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00. 20 ANDA NO.:077627 THERAPEUT ICE USE: ANTICONVULSANT TO PIRAMATE TAB 100MG 500 NDC CO DE:68462010905 FDA PRODUCT CO DE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO.: 77627 THERAPEUTICE USE: :#A NTICONVULSANT OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:68462 039710 FDA PRODUCT CODE NO.: 62KCF10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE U SE: -TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE ATOMOXETINE CAP 10MG 30 NDC CODE:68462026530 FDA PRODUCT CODE NO.: 64 UCA 99 H. T. S NO.: 3004.90.92.90 ANDA NO. : 079019 THERAPEUTICE USE : - ATOMOXETINE IS USED TO TREA T ATTENTION-DEFICIT HYPERACTI VITY DISORDER (ADHD) AS PART OF A TOTAL TREATMENT PLAN, IN CLUDING PSYCHOLOGICAL, SOCIAL , AND OTHER TREATMENTS THE OPHYLLINE ER TAB 300MG 100 ND C CODE:68462072101 FDA PRODUC T CODE NO :63 B C B 30 HTS N O.3004.90.9289 ANDA NO.90-355 THERAPEUTICE USE:-XANTHINE BRONCHODILATOR COMMERCIAL & CUSTOM INVOICE NO. F2245200 5138 DT. 23.01.2024 F22452005 159 DT. 24.01.2024 F224520052 16 DT. 28.01.2024 F2245200521 5 DT. 28.01.2024 S/BILL NO: 7 099188 DT 29-JAN-2024 S/BILL NO: 7100172 DT 29-JAN-2024 S/ BILL NO: 7100176 DT 29-JAN-202 4 S/BILL NO: 7099182 DT 29-JA N-2024 NET WT. 7,105.73 KGS 02 DATA LOGGERS SET TEMP ERATURE : +20 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA
2024-03-08 MAEU235919187 GLENMARK PHARMACEUTICALS LTD 6281.45 kg 652700 34 PALLETS 1700 CARTONS PH ARMACEUTICALS AS UNDER NORG EST/EE TAB .18,.215,.25/.035MG 84 NDC CODE:68462056529 FDA PRODUCT CODE NO.: 65 J D A 2 7 H. T. S NO.: 300660.00.00 ANDA NO.: 200494 THERAPEUTIC E USE: - ORAL CONTRACEPTIVES NORGEST/EE TAB .18,.215,.25 /.035MG 84 NDC CODE:684620565 29 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.6 0.00.00 ANDA NO.: 200494 THE RAPEUTICE USE: - ORAL CONTRAC EPTIVES COMMERCIAL & CUSTOM INVOICE NO. F22452005155 DT. 24.01.2024 F22452005167 DT. 25.01.2024 S/BILL NO: 7027001 DT 25-JAN-2024 S/BILL NO: 70 35045 DT 25-JAN-2024 NET WT: 4920.000 KGS 02 DATA LOGGERS SET TEMPERATURE : +20 DEGR EES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA
2024-03-08 MAEU235804475 GLENMARK PHARMACEUTICALS LTD 3835.19 kg 653900 28 PALLETS 1368 CARTONS PH ARMACEUTICALS AS UNDER DROS PIRENONE/EE TAB 3/0.02MG 84 N DC CODE:68462072029 FDA PRODU CT CODE NO.: 65 J D A 39 H. T. S NO.: 300660.00.00 ANDA NO.: 204296 THERAPEUTICE USE: - ORAL CONTRACEPTIVE COMM ERCIAL & CUSTOM INVOICE NO. F 22452005132 DT. 23.01.2024 S/ BILL NO: 6986328 DT:24-JAN-24 NET WT. 2790.720 KGS 01 DAT A LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA
2024-03-08 MAEU235518718 GLENMARK PHARMACEUTICALS LTD 2068.42 kg 652500 12 PALLETS 600 CARTONS PHA RMACEUTICALS AS UNDER HAILE Y FE 1.5/30 TAB 1.5MG/30MCG-75 MG 84 NDC CODE:68462050329 F DA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00. 00 ANDA NO.:206597 THERAPEUT ICE USE: HORMONE MEDICATION I S USED TO PREVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F22452005133 DT. 23.01.2 024 S/BILL NO: 6985740 DT:24- JAN-24 NET WT. 1,526.40 KGS 12 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S .A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND
2024-03-08 MAEU235518713 GLENMARK PHARMACEUTICALS LTD 9088.78 kg 300490 43 PALLETS 2308 CARTONS PHAR MACEUTICALS AS UNDER NORETH A CE/EE TAB 1/0.02MG 63 NDC COD E:68462013281 FDA PRODUCT COD E NO.:65 J C A 25 H. T. S NO .: 3006.60.00.00 ANDA NO.:20 6969 THERAPEUTICE USE: - SEC ONDARY AMENORRHEA,ENDOMETRIOS IS AND ABNORMAL UTERINE BLE EDING NORGEST/EE TAB 0.25/0.0 35MG 84 NDC CODE:68462030929 FDA PRODUCT CODE NO.: 65 J D A 27 H. T. S NO.: 3006.60.0 0.00 ANDA NO.: 200538 THERAP EUTICE USE: - ORAL CONTRACEPT IVES GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PR ODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT TOPIRAMATE TAB 1 00MG 500 NDC CODE:68462010905 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49. 00.20 ANDA NO.: 77627 THERAP EUTICE USE: :#ANTICONVULSANT RILUZOLE TAB 50MG 60 NDC COD E:68462038160 FDA PRODUCT COD E NO.: 62 J C A 16 H. T. S N O.: 3004.90.92.30 ANDA NO.: 91394 THERAPEUTICE USE: - A- PARKINSONIAN/ HUMAN - RX/SING LE INGREDIENT / PROMPT RELEAS E TABLETS / RILUZOLE (ANTI-P ARKINSONIAN) ACAMPROSATE CALC IUM DR TAB 333MG 180 NDC CODE :68462043518 FDA PRODUCT CODE NO.: 60 T C C 99 H. T. S NO .: 3004.90.92.40 ANDA NO.:20 2229 THERAPEUTICE USE: - FOR TREATING ALCOHOL DEPENDENCE COMMERCIAL & CUSTOM INVOICE N O. F22452005203 DT. 27.01.202 4 F22452005208 DT. 27.01.2024 F22452005137 DT. 23.01.2024 F22452005211 DT. 27.01.2024 F22452005210 DT. 27.01.2024 S /BILL NO:7082761 DT 29-JAN-202 4 S/BILL NO:7082772 DT 29-JAN -2024 S/BILL NO:7088591 DT 29 -JAN-2024 S/BILL NO:7082773 D T 29-JAN-2024 S/BILL NO:70897 12 DT 29-JAN-2024 NET WT. 7,5 39.83 KGS 02 DATA LOGGERS SE T TEMPERATURE : +20 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430
2024-02-28 MAEU235143544 GLENMARK PHARMACEUTICALS LTD 9487.5 kg 300490 40 PALLETS 3137 CARTONS PH ARMACEUTICALS AS UNDER MUPI ROCIN CREAM 2% 15GM NDC CODE: 68462056417 FDA PRODUCT CODE NO.: 61GCJ82 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 201587 THERAPEUTICE USE: - TOPICAL ANTI-BACTERIAL NAPROXEN TA B 500MG 30 NDC CODE:684620190 30 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:-78-250 THE RAPEUTICE USE:-ANTI-INFLAMMAT ORY, ANALGESIC NAPROXEN TA B 500MG 500 NDC CODE:68462019 005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004. 90.92.40 ANDA NO.:-78-250 TH ERAPEUTICE USE:-ANTI-INFLAMMA TORY, ANALGESIC CARVEDILOL TAB 3.125MG 500 NDC CODE:684 62016205 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90. 9221 ANDA NO.78-251 THERAPEU TICE USE:-BETA- ADRENOACEPTO R ANTAGONIST OMEPRAZOLE DR CAP 40MG 100 NDC CODE:684620 39701 FDA PRODUCT CODE NO.:6 2KCF10 HTS NO.3004.90.9255 A NDA NO.:91672 THERAPEUTICE US E: -TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE TOPIRAMATE TAB 50MG 60 NDC C ODE:68462015360 FDA PRODUCT C ODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.20 ANDA NO. :- 77-627 THERAPEUTICE USE:- ANTICONVULSANT OMEPRAZOLE D R CAP 40MG 90 NDC CODE:684620 39790 FDA PRODUCT CODE NO.:6 2KCF10 HTS NO.3004.90.9255 A NDA NO.:91672 THERAPEUTICE US E: -TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE ZONISAMIDE CAP 25MG 100 NDC CODE:68462012801 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO .:-77-651 THERAPEUTICE USE:- ANTISEIZURE DRUG PRAMIPEXOL E TAB 1.5MG 90 NDC CODE:68462 033490 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 30 04.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USED IN PA RKINSON#S DISEASE OMEPRAZOL E DR CAP 40MG 90 NDC CODE:684 62039790 FDA PRODUCT CODE NO .:62KCF10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GA STROESOPHAGEAL REFLUX DISEASE COMMERCIAL & CUSTOM INVOIC E NO. F22452004892 DT. 09.01. 2024 F22452004887 DT. 09.01.2 024 F22452004889 DT. 09.01.20 24 F22452004888 DT. 09.01.202 4 F22452004893 DT. 09.01.2024 F22452004901 DT. 10.01.2024 S/BILL NO: 6659998 DT 10-JAN- 2024 S/BILL NO: 6656859 DT 10 -JAN-2024 S/BILL NO: 6656861 DT 10-JAN-2024 S/BILL NO: 665 8461 DT 10-JAN-2024 S/BILL NO : 6656860 DT 10-JAN-2024 S/BI LL NO: 6659141 DT 10-JAN-2024 NET WT. 7774.591 KGS 02 DA TA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
2024-02-28 MAEU235143542 GLENMARK PHARMACEUTICALS LTD 11186.68 kg 300490 52 PALLETS 2630 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 10MG 1000 NDC CO DE:68462026210 61 J C A 16 3 004.49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT C ARDIOVASCULAR DISEASE ATOMO XETINE CAP 18MG 30 NDC CODE:6 8462026630 FDA PRODUCT CODE N O.: 64 UCA 99 H. T. S NO.: 3004.90.92.90 ANDA NO.: 07901 9 THERAPEUTICE USE : - ATOMO XETINE IS USED TO TREAT ATTEN TION-DEFICIT HYPERACTIVITY DI SORDER (ADHD) AS PART OF A TO TAL TREATMENT PLAN, INCLUDING PSYCHOLOGICAL, SOCIAL, AND OTHER TREATMENTS OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:68 462039710 FDA PRODUCT CODE N O.:62KCF10 HTS NO.3004.90.925 5 ANDA NO.:91672 THERAPEUTIC E USE: -TREATMENT OF TREAT G ASTROESOPHAGEAL REFLUX DISEAS E OMEPRAZOLE DR CAP 40MG 90 NDC CODE:68462039790 FDA PR ODUCT CODE NO.:62KCF10 HTS N O.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE ROPINIROLE T AB 0.5MG 100 NDC CODE:6846202 5401 FDA PRODUCT CODE NO.:-6 2 J C A 17 H. T. S NO.: 3004 .90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TREATMENT O F PARKINSONISM CLOTRIMAZOL E CREAM 1% 30GM NDC CODE:6846 2018135 FDA PRODUCT CODE NO :61 W C J 04 HTS NO.3004.90.9 240 ANDA NO.90-219 THERAPEUT ICE USE:-TREATMENT OF CANDID IASIS COMMERCIAL & CUSTOM I NVOICE NO. F22452004926 DT. 1 1.01.2024 F22452004927 DT. 11 .01.2024 F22452004928 DT. 11. 01.2024 S/BILL NO: 6701711 DT 12-JAN-2024 S/BILL NO: 67017 30 DT 12-JAN-2024 S/BILL NO:6 701707 DT 12-JAN-2024 NET WT. 9,409.37 KGS 12 DATA LOGGE RS SET TEMPERATURE : +20 DE GREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PA RTY:3 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWI TZERLAND
2024-02-02 MAEU234951950 GLENMARK PHARMACEUTICALS LTD 687.66 kg 662800 3 PALLETS 86 CARTONS PHARM ACEUTICALS AS UNDER NITROGL YCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FDA PRO DUCT CODE NO.: 66 S C A 28 H . T. S NO.: 3004.90.9020 AND A NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR HEART FAILURE,HIGH BLOOD PRESSURE,A ND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BLOOD F LOW TO THE HEART COMMERCIA L & CUSTOM INVOICE NO. F22487 001750 DT. 30.12.2023 S/BILL NO: 4020297 DT: 30/12/2023 NE T WT. 45.82 KGS 03 DATA LOG GERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLE NMARK SPECIALTY S.A. SWITZERL AND (GSSA) PLACE DU PORT 2 N EUCHATEL - 2000 SWITZERLAND
2024-02-02 MAEU234708639 GLENMARK PHARMACEUTICALS LTD 6926.93 kg 300490 37 PALLETS 2335 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO .:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA RUFINAMIDE TAB 400MG 120 NDC CODE:6846207140 8 61 M C A 99 3004.90.92.30 205075 TO USED WITH OTHER M EDICATIONS TO PREVENT OR CONT ROL SEIZURES (EPILEPSY) ASSO CIATED WITH LENNOX-GASTAUT S YNDROME (LGS SAXAGLIPTIN TA B 5MG 30 NDC CODE:68462072730 FDA PRODUCT CODE NO.:61 P C A 99 H. T. S NO.: 3004.90.9 220 ANDA NO.:205994 THERAPEU TICE USE: :#ANTI-DIABETIC AGE NT INDOMETHACIN ER CAP 75MG 60 NDC CODE:68462032560 FDA PRODUCT CODE: 62 GCE42 H. T . S NO.:3004.90.92.40 ANDA N O.203501 THERAPEUTIC USE: IN DOMETHACIN IS USED TO RELIEVE PAIN, SWELLING, AND JOINT ST IFFNESS CAUSED BY ARTHRITIS, GOUT, BURSITIS, AND TENDONITI S. IT IS ALSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CON DITIONS. THIS MEDICATION IS K NOWN AS A NONSTEROIDAL ANTI- INFLAMMATORY DRUG (NSAID). .. . THIS EFFECT HELPS TO DECRE ASE SWELLING AND PAIN. FEN OFIBRATE CAP 200MG 100 NDC CO DE:68462058201 FDA PRODUCT CO DE NO.: 61 JCE 09 H. T. S NO .: 3004.90.92.20 ANDA NO.: 2 05566 THERAPEUTICE USE: - IN DICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDE S AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTERO LEMIA OR MIXED DYSLIPIDEMIA FENOFIBRATE CAP 134MG 100 N DC CODE:68462058101 FDA PRODU CT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA N O.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIVE TH ERAPY TO DIET FOR THE REDUCTI ON OF LDL-C, TOTAL-C, TRIGLYC ERIDES AND APO B IN DULT PAT IENTS WITH PRMARY HYPERCHOLE STEROLEMIA OR MIXED DYSLIPIDE MIA NAPROXEN SOD TAB 275MG 100 NDC CODE:68462017801 FDA PRODUCT CODE NO.:-62 G C A 5 0 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-314 THERAPEUTI CE USE:-ANTI -INFLAMMATORY, A NALGESIC TACROLIMUS OINT 0. 1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49. 00.50 ANDA NO.: 210393 THERA PEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATME NT OF MODERATE-TO-SEVERE ATO PIC DERMATITIS (ECZEMA). T ACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT E-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS CAP 0.5MG 100 NDC CODE:6846206850 1 FDA PRODUCT CODE NO.: 64 T C E 08 H. T. S NO.:3004.90. 92.15 ANDA NO.: 206662 THERA PEUTICE USE: :#TO PREVENT REJ ECTION OF A KIDNEY,TO PREVENT REJECTION OF A KIDNEY,LIVER TRANSPLANT TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HTS NO: 3004.90.92.15 FDA CO DE : 64 T C E 08 ANDA NO.2066 62 THERAPEUTIC USE : TO PREV ENT REJECTION OF A KIDNEY,HEA RT, OR LIVER TRANSPLANT CO MMERCIAL & CUSTOM INVOICE NO. F22487001748 DT. 30.12.2023 F22487001749 DT. 30.12.2023 S /BILL NO: 4020294 DT:30/12/202 3 S/BILL NO: 4020292 DT:30/12 /2023 NET WT. 3110.165 KGS 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA
2024-02-02 MAEU234918422 GLENMARK PHARMACEUTICALS LTD 6262.86 kg 653900 42 PALLETS 2450 CARTONS PH ARMACEUTICALS AS UNDER DROS PIRENONE/EE TAB 3/0.03MG 84 N DC CODE:68462073329 FDA PRODU CT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204848 THERAPEUTICE USE : - CONTRACEPTION TO PREVENT PREGNANCY ASHLYNA TAB 0.15 /0.03MG-0.01MG 182 NDC CODE:6 8462064693 FDA PRODUCT CODE N O.: 64 G D A 2 H. T. S NO.: 3006.60.0000 ANDA NO.: 20316 3 THERAPEUTICE USE: - INDICA TED FOR USE BY WOMEN TO PREVE NT PREGNANCY CARVEDILOL TA B 6.25MG 500 NDC CODE:6846201 6305 FDA PRODUCT CODE NO : 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST ONDAN SETRON TAB 8MG 30 NDC CODE:68 462010630 FDA PRODUCT CODE N O.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 77-5 35 THERAPEUTICE USE:-ANTI -E METIC COMMERCIAL & CUSTOM I NVOICE NO. F22452004826 DT. 3 1.12.2023 F22452004827 DT. 31 .12.2023 F22452004795 DT. 31. 12.2023 F22452004800 DT. 31.1 2.2023 S/BILL NO: 6477035 DT: 02-JAN-24 S/BILL NO: 6477050 DT:02-JAN-24 S/BILL NO:64770 37 DT:02-JAN-24 S/BILL NO: 64 77051 DT:02-JAN-24 NET WT. 47 11.450 03 DATA LOGGERS HU MIDITY:65% SET TEMPERATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA
2024-02-02 MAEU234918428 GLENMARK PHARMACEUTICALS LTD 12037.18 kg 684620 51 PALLETS 4714 CARTONS PH ARMACEUTICALS AS UNDER PRAM IPEXOLE TAB 0.125MG 90 NDC CO DE:68462033090 FDA PRODUCT CO DE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USE D IN PARKINSON#S DISEASE R OPINIROLE TAB 2MG 100 NDC COD E:68462025601 FDA PRODUCT COD E NO.:-62 J C A 17 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TR EATMENT OF PARKINSONISM ON DANSETRON TAB 4MG 30 NDC CODE :68462010530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUTICE USE:-ANTI -EMETIC CARVEDILOL TAB 25 MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92 .20 ANDA NO.:- 78-251 THERAP EUTICE USE:-BETA- ADRENOACEP TOR ANTAGONIST TELMISARTAN TAB 40MG 30 NDC CODE:6846202 0030 FDA PRODUCT CODE NO.: 6 2 O C A 09 H. T. S NO.: 3004 .90.92.20 ANDA NO.:090032 TH ERAPEUTICE USE: INDICATED FOR THE TREATMENT OF HYPERTENSI ON, TO LOWER BLOOD PRESSURE ZONISAMIDE CAP 100MG 100 ND C CODE:68462013001 FDA PRODUC T CODE NO.:-61 M C E 44 H. T . S NO.: 3004.49.00.20 ANDA NO.:-77-651 THERAPEUTICE USE :-ANTISEIZURE DRUG ROPINIRO LE TAB 0.5MG 100 NDC CODE:684 62025401 FDA PRODUCT CODE NO .:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-1 35 THERAPEUTICE USE:-TREATME NT OF PARKINSONISM CARVEDI LOL TAB 6.25MG 500 NDC CODE:6 8462016305 FDA PRODUCT CODE N O : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78 -251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST PRAVASTATIN SOD TAB 40MG 500 NDC CODE:68462019705 FDA PRO DUCT CODE NO.: 61 J C A 13 H . T. S NO.: 3004.90.92.20 AN DA NO.: 77-987 THERAPEUTICE U SE: -HYPOLIPDAEMIC PRAVAST ATIN SOD TAB 40MG 90 NDC CODE :68462019790 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO .: 3004.90.92.20 ANDA NO.: 7 7-987 THERAPEUTICE USE: -HYP OLIPDAEMIC GABAPENTIN TAB 6 00MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-662 THERAP EUTICE USE:-ANTICONVULSANT A GENT OXCARBAZEPINE TAB 600M G 100 NDC CODE:68462013901 F DA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92. 30 ANDA NO.:-77-802 THERAPEU TICE USE:-ANTI CONVULSANT AGE NT COMMERCIAL & CUSTOM INVO ICE NO. F22452004648 DT. 28.1 2.2023 F22452004649 DT. 28.12 .2023 F22452004696 DT. 29.12. 2023 F22452004697 DT. 29.12.2 023 F22452004735 DT. 30.12.20 23 F22452004752 DT. 30.12.202 3 S/BILL NO: 6460329 DT 01-JA N-2024 S/BILL NO:6460324 DT 0 1-JAN-2024 S/BILL NO: 6460328 DT 01-JAN-2024 S/BILL NO: 64 60323 DT 01-JAN-2024 S/BILL N O:6460326 DT 01-JAN-2024 S/BI LL NO: 6460325 DT 01-JAN-2024 NET WT. 9997.284 KGS 02 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA
2024-02-02 MAEU234708651 GLENMARK PHARMACEUTICALS LTD 4012.55 kg 642900 32 PALLETS 1112 CARTONS PH ARMACEUTICALS AS UNDER LEVO NORGESTREL/EE TAB 0.15/0.03MG 273 NDC CODE:68462067295 FDA PRODUCT CODE NO.: 64 G D A 2 9 H. T. S NO.: 3006.60.0000 ANDA NO.: 203164 THERAPEUTIC E USE: - CONTRACEPTION TO PRE VENT PREGNANCY NORETHINDRO NE TAB 0.35MG 84 NDC CODE:684 62030529 FDA PRODUCT CODE NO. : 65 J C A 26 H. T. S NO.: 3006.60.00.00 ANDA NO.:91-209 THERAPEUTICE USE: PREVENTIO N OF PREGNANCY. ESTRADIOL V AG INSERTS 10MCG 8 NDC CODE:6 8462071171 FDA PRODUCT CODE N O.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA NO.:2102 64 THERAPEUTICE USE:THE TREA TMENT OF ATROPIC VAGINITIS DU E TO MENOPAUSE. COMMERCIAL & CUSTOM INVOICE NO. F224520 04740 DT. 30.12.2023 F2245200 4747 DT. 30.12.2023 F22452004 749 DT. 30.12.2023 S/BILL NO: 6465166 DT 02-JAN-2024 S/BIL L NO:6465154 DT 02-JAN-2024 S /BILL NO:6466046 DT 02-JAN-202 4 NET WT. 2878.440 KGS 02 DATA LOGGERS SET TEMPERATUR E : +20 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA
2024-02-02 MAEU234918436 GLENMARK PHARMACEUTICALS LTD 3335.32 kg 642800 22 PALLETS 1225 CARTONS PH ARMACEUTICALS AS UNDER ESTR ADIOL VAG INSERTS 10MCG 8 NDC CODE:68462071171 FDA PRODUCT CODE NO.: 64 G C A 28 H. T. S NO.: 3006.60.00.00 ANDA N O.:210264 THERAPEUTICE USE:TH E TREATMENT OF ATROPIC VAGIN ITIS DUE TO MENOPAUSE. DRO SPIRENONE/EE TAB 3/0.03MG 84 NDC CODE:68462073329 FDA PROD UCT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 AND A NO.: 204848 THERAPEUTICE US E: - CONTRACEPTION TO PREVENT PREGNANCY COMMERCIAL & CU STOM INVOICE NO. F22452004758 DT. 31.12.2023 F22452004825 DT. 31.12.2023 S/BILL NO:6460 880 DT 01-JAN-2024 S/BILL NO: 6460878 DT 01-JAN-2024 NET WT . 2375.400 KGS 02 DATA LOGG ERS SET TEMPERATURE : +20 DEG REES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA
2024-02-02 MAEU234987226 GLENMARK PHARMACEUTICALS LTD 3055.45 kg 652500 18 PALLETS 892 CARTONS PHA RMACEUTICALS AS UNDER HAILE Y FE 1.5/30 TAB 1.5MG/30MCG-75 MG 84 NDC CODE:68462050329 F DA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00. 00 ANDA NO.:206597 THERAPEUT ICE USE: HORMONE MEDICATION I S USED TO PREVENT PREGNANCY COMMERCIAL & CUSTOM INVOICE NO. F22452004779 DT. 31.12.2 023 S/BILL NO: 6460879 DT. 01 -JAN-2024 NET WT. 2,269.25 K GS 18 DATA LOGGERS SET TEMP ERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S. A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 S WITZERLAND
2024-02-02 MAEU235123221 MANKIND PHARMA LTD 1337.67 kg 650121 8 PALLETS 896 CARTONS PHA RMACEUTICALS AS UNDER VAREN ICLINE TABLETS 1 MG, 56CT NDC NO. : 68462-894-56 FDA PRODU CT CODE : 65ZCA01 ANDA NO. : 214255 H. T. S NO.: 3004.90. 99 THERAPEUTIC USE : USE AS AN AID TO SMOKING CESSATION T REATMENT VARENICLINE TABLET S 1 MG, 56CT NDC NO. : 68462- 894-56 FDA PRODUCT CODE : 65Z CA01 ANDA NO. : 214255 H. T. S NO.: 3004.90.99 THERAPEUT ICE USE: USE AS AN AID TO SMO KING CESSATION TREATMENT CO MMERCIAL & CUSTOM INVOICE NO. 832435288 DTD 29.12.2023 S/B ILL NO: 6400920 DT 29-DEC-2023 NET WT. 252.670 KGS 02 DAT A LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA
2024-02-02 MAEU234918434 GLENMARK PHARMACEUTICALS LTD 5152.9 kg 300490 30 PALLETS 1943 CARTONS P HARMACEUTICALS AS UNDER TAC ROLIMUS OINT 0.1% 60GM NDC CO DE:68462053465 FDA PRODUCT CO DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). EZETIMIBE-SIMVA T AB 10/20MG 30 NDC CODE:684620 32230 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 300 4.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: :#LIPID LOW ERING AGENT CLINDAMYCIN HCL CAP 150MG 500 NDC CODE:68462 014305 FDA PRODUCT CODE NO.: 56 J C E 20 H. T. S NO.: 294 1.90.5000 ANDA NO.:216957 TH ERAPEUTICE USE: :#TREATMENT O F NUMEROUS INFECTIONS, INCLUD ING BUT NOT LIMITED TO SEPT ICEMIA,INTRAABDOMINAL INFECTI ONS, LOWER RESPIRATORY INFEC TIONS, GYNECOLOGICAL INFECTIO NS, BONE AND JOINT INFECTIONS , AND SKIN AND SKIN STRUCTURE INFECTIONS RUFINAMIDE TAB 400MG 120 NDC CODE:684620714 08 61 M C A 99 3004.90.92.30 205075 TO USED WITH OTHER MEDICATIONS TO PREVENT OR CON TROL SEIZURES (EPILEPSY) ASS OCIATED WITH LENNOX-GASTAUT SYNDROME (LGS CLINDAMYCIN H CL CAP 150MG 500 NDC CODE:684 62014305 FDA PRODUCT CODE NO .:56 J C E 20 H. T. S NO.: 2 941.90.5000 ANDA NO.:216957 THERAPEUTICE USE: :#TREATMENT OF NUMEROUS INFECTIONS, INCL UDING BUT NOT LIMITED TO SE PTICEMIA,INTRAABDOMINAL INFEC TIONS, LOWER RESPIRATORY INF ECTIONS, GYNECOLOGICAL INFECT IONS, BONE AND JOINT INFECTIO NS, AND SKIN AND SKIN STRUCTU RE INFECTIONS TACROLIMUS C AP 1MG 100 NDC CODE:684620686 01 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.2 06662 THERAPEUTIC USE : TO P REVENT REJECTION OF A KIDNEY, HEART, OR LIVER TRANSPLANT BISOPROLOL-HCTZ TAB 5/6.25MG 100 NDC CODE:68462087901 FDA PRODUCT CODE NO.: 62 O D A 1 8 H. T. S NO.: 3004.40.00.20 ANDA NO.: 215995 THERAPEUTI CE USE: BISOPROLOL FUMARATE A ND HYDROCHLOROTHIAZIDE TABLE TS ARE INDICATED IN THE MANA GEMENT OF HYPERTENSION. BI SOPROLOL-HCTZ TAB 10/6.25MG 50 0 NDC CODE:68462088005 FDA P RODUCT CODE NO.: 62 O D A 18 H. T. S NO.: 3004.40.00.20 ANDA NO.: 215995 THERAPEUTICE USE: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE TABLETS ARE INDICATED IN THE MANAGE MENT OF HYPERTENSION. SOLI FENACIN SUCCINATE TAB 10MG 30 NDC CODE:68462038730 FDA PRO DUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICATED FOR TH E TREATMENT OF OVERACTIVE BL ADDER WITH SYMPTOMS OF URGE U RINARY INCONTINENCE, URGENCY AND URINARY FREQUENCY SOLI FENACIN SUCCINATE TAB 10MG 90 NDC CODE:68462038790 FDA PRO DUCT CODE NO.: 61 KCA 72 H. T. S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICATED FOR TH E TREATMENT OF OVERACTIVE BL ADDER WITH SYMPTOMS OF URGE U RINARY INCONTINENCE, URGENCY AND URINARY FREQUENCY COMM ERCIAL & CUSTOM INVOICE NO. F 22487001778 DT. 31.12.2023 F2 2487001779 DT. 31.12.2023 F22 487001780 DT. 31.12.2023 F224 87001789 DT. 31.12.2023 F2248 7001797 DT. 31.12.2023 F22487 001823 DT. 04.01.2024 F224870 01824 DT. 04.01.2024 S/BILL N O: 4000147 DT: 04/01/2024 S/B ILL NO: 4000145 DT: 04/01/2024 S/BILL NO: 4000137 DT: 04/01 /2024 S/BILL NO: 4000142 DT: 04/01/2024 S/BILL NO: 4000144 DT: 04/01/2024 S/BILL NO: 40 00149 DT: 04/01/2024 S/BILL N O: 4000148 DT: 04/01/2024 NET WT. 1732.873 KGS HUMIDITY:6 5% SET TEMPERATURE : +20 DEGR EES TEMPERATURE RANGE : +15 D EGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S.A. SWITZERLAND (G SSA) PLACE DU PORT 2 NEUCHAT EL - 2000 SWITZERLAND
2024-01-19 MAEU234364685 GLENMARK PHARMACEUTICALS LTD 363.79 kg 684620 2 PALLETS 121 CARTONS PHAR MACEUTICALS AS UNDER ROSUVA STATIN TAB 10MG 1000 NDC CODE :68462026210 61 J C A 16 300 4.49.00.10 79172 TO TREAT HI GH CHOLESTEROL AND RELATED CO NDITIONS, AND TO PREVENT CAR DIOVASCULAR DISEASE . COMMERCIAL & CUSTOM INVOICE NO . F22452004414 DT. 12.12.2023 S/BILL NO: 6005163 DT 13-DEC -2023 NET WT. 314.79 KGS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES NOTIFY PARTY :2 GLENMARK SPECIALTY S.A. S WITZERLAND (GSSA) PLACE DU PO RT 2 NEUCHATEL - 2000 SWITZE RLAND
2024-01-19 MAEU234234484 GLENMARK PHARMACEUTICALS LTD 7825.96 kg 642700 40 PALLETS 2274 CARTONS PH ARMACEUTICALS AS UNDER VIOR ELE TAB 0.15/0.02-0.01MG 84 N DC CODE:68462031829 FDA PRODU CT CODE NO.: 64 G D A 27 H. T. S NO.: 3004.39.00.50 ANDA NO.: 091346 THERAPEUTICE USE : - ORAL CONTRACEPTIVES NO RETHINDRONE ACE TAB 5MG 50 ND C CODE:68462030450 FDA PRODUC T CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO .:-91-090 THERAPEUTICE USE:- SECONDARY AMENORRHEA,ENDOMET RIOS IS AND ABNORMAL UTERINE BLEEDING OLMESARTAN MEDOX TAB 20MG 90 NDC CODE:68462043 790 FDA PRODUCT CODE NO.: 62 CCA68 H. T. S NO.: 3004.90.9 220 ANDA NO.: 203281 THERAPE UTICE USE: - -TREATMENT OF H YPERTENSION, ALONE OR WITH OT HER ANTIHYPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE CL OTRIMAZOLE CREAM 1% 15GM NDC CODE:68462018117 FDA PRODUCT CODE NO.:61#W#C#J#04 H. T. S NO.: 3004.90.92.45 ANDA NO. : 90-219 THERAPEUTICE USE: T REATMENT OF CANDIDIASIS COM MERCIAL & CUSTOM INVOICE NO. F22452004411 DT. 12.12.2023 F 22452004413 DT. 12.12.2023 F2 2452004412 DT. 12.12.2023 F22 452004416 DT. 12.12.2023 S/BI LL NO: 6005159 DT 13-DEC-2023 S/BILL NO: 6007613 DT 13-DEC- 2023 S/BILL NO: 6005168 DT 13 -DEC-2023 S/BILL NO: 6005694 DT 13-DEC-2023 NET WT. 6098.8 90 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
2024-01-19 MAEU234234636 GLENMARK PHARMACEUTICALS LTD 9705.23 kg 684620 40 PALLETS 2128 CARTONS PH ARMACEUTICALS AS UNDER LAMO TRIGINE TAB CD 25MG 100 NDC C ODE:68462022901 FDA PRODUCT C ODE NO.:- 61 M C A 38 H. T. S NO.: 3004.90.92.30 ANDA NO .:-79 # 099 THERAPEUTICE USE: - ANTICONVULSANT THEOPHYLL INE ER TAB 400MG 100 NDC CODE :68462038001 FDA PRODUCT CODE NO.: 63 B C B 30 H. T. S NO .: 3004.90.92.85 ANDA NO.: 9 0-355 THERAPEUTICE USE: XANT HINE BRONCHODILATOR CLOTRIM AZOLE CREAM 1% 30GM NDC CODE: 68462018135 FDA PRODUCT CODE NO :61 W C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90- 219 THERAPEUTICE USE: TREATM ENT OF CANDIDIASIS CLOTRIMA ZOLE CREAM 1% 45GM NDC CODE:6 8462018147 FDA PRODUCT CODE N O :61 W C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-2 19 THERAPEUTICE USE: TREATME NT OF CANDIDIASIS NORETHIND RONE ACE TAB 5MG 50 NDC CODE: 68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO.:-91-0 90 THERAPEUTICE USE:- SECOND ARY AMENORRHEA,ENDOMETRIOS I S AND ABNORMAL UTERINE BLEEDI NG HAILEY 1.5/30 TAB 1.5MG/ 30MCG 63 NDC CODE:68462050481 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60. 00.00 ANDA NO.: 209297 THERA PEUTICE USE: - CONTRACEPTION TO PREVENT PREGNANCY COM MERCIAL & CUSTOM INVOICE NO. F22452004444 DT. 14.12.2023 F 22452004445 DT. 14.12.2023 F2 2452004443 DT. 14.12.2023 F22 452004456 DT. 14.12.2023 F224 52004457 DT. 14.12.2023 S/BIL L NO: 6059648 DT 15-DEC-2023 S/BILL NO: 6059649 DT 15-DEC-2 023 S/BILL NO: 6059674 DT 15- DEC-2023 S/BILL NO: 6059645 D T 15-DEC-2023 S/BILL NO: 6059 654 DT 15-DEC-2023 NET WT. 6 500.780 KGS 20 DATA LOGGERS SET TEMPERATURE : +20 DEGR EES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA NOTIFY PART Y:3 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU P ORT 2 NEUCHATEL - 2000 SWITZ ERLAND
2024-01-19 MAEU234234635 GLENMARK PHARMACEUTICALS LTD 9601.35 kg 611500 41 PALLETS 2604 CARTONS PH ARMACEUTICALS AS UNDER EZET IMIBE TAB 10MG 30 NDC CODE:68 462022630 FDA PRODUCT CODE NO .: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #078 560 THERAPEUTICE USE: LIPID LOWERING AGENT PRAVASTATIN SOD TAB 80MG 90 NDC CODE:6846 2019890 FDA PRODUCT CODE NO. :-61 J C A 13 H. T. S NO.: 3 004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE:-HYPOLIPDA EMIC PRAVASTATIN SOD TAB 20 MG 500 NDC CODE:68462019605 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92 .20 ANDA NO.:-77-987 THERAPE UTICE USE:-HYPOLIPDAEMIC C ARVEDILOL TAB 25MG 500 NDC CO DE:68462016505 FDA PRODUCT CO DE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.: - 78-251 THERAPEUTICE USE:-B ETA- ADRENOACEPTOR ANTAGONIS T PIMECROLIMUS CREAM 1% 100 GM NDC CODE:68462060994 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTIC E USE: - AS SECOUND-LINE THER APY FOR THE SHORT-TERM AND N ON-CONTINUOS CHRONIC TRERTMEN T OF MILD TO MODERATE ATOPIC DERMATITIS IN NON- IMMUNOCO MPROMISED ADULT AND CHILDREN 2 YEARS OF AGE PIMECROLIMU S CREAM 1% 60GM NDC CODE:6846 2060965 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3 004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS SECO UND-LINE THERAPY FOR THE SHOR T-TERM AND NON-CONTINUOS CHRO NIC TRERTMENT OF MILD TO MOD ERATE ATOPIC DERMATITIS IN N ON- IMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PROD UCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 AND A NO.: 210393 THERAPEUTICE US E: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT U SED FOR THE TREATMENT OF MOD ERATE-TO-SEVERE ATOPIC DERMAT ITIS (ECZEMA). TACROLIMUS OINT 0.1% 30GM NDC CODE:68462 053435 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 30 04.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIM US IS A TOPICAL IMMUNOSUPPRES SIVE OINTMENT USED FOR THE T REATMENT OF MODERATE-TO-SEVER E ATOPIC DERMATITIS (ECZEMA) . POTASSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FD A PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.9 0 ANDA NO.: 202868 THERAPEUT ICE USE: - TREATMENT OR PREVE NTION OF HYPOKALEMIA COMME RCIAL & CUSTOM INVOICE NO. F2 2487001625 DT. 13.12.2023 F22 487001627 DT. 13.12.2023 F224 87001628 DT. 13.12.2023 F2248 7001629 DT. 13.12.2023 S/BILL NO: 4019222 DT: 14/12/2024 S /BILL NO: 4019224 DT: 14/12/20 24 S/BILL NO: 4019220 DT: 14/ 12/2024 S/BILL NO: 4019222 DT : 14/12/2024 NET WT. 6496.525 KGS 02 DATA LOGGERS SET T EMPERATURE : +20 DEGREES NO TIFY PARTY:2 GLENMARK PHARMAC EUTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07 430 USA
2024-01-19 MAEU234412719 GLENMARK PHARMACEUTICALS LTD 210.47 kg 613200 2 PALLETS 128 CARTONS PHAR MACEUTICALS AS UNDER APREPI TANT CAP 80MG 6UD NDC CODE:68 462058476 FDA PRODUCT CODE NO .: 61 T C E 32 H. T. S NO.: 3004.90.92.40 ANDA NO.:20777 7 THERAPEUTICE USE:APREPITAN T IS USED WITH OTHER MEDICATI ONS TO HELP PREVENT NAUSEA AN D VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOTHERAPY) . THIS MEDICATION IS ALSO USE D TO PREVENT NAUSEA AND VOMI TING AFTER SURGERY. A-EMETIC/ NAUSEANT / HUMAN - RX/SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT NITR OGLYCERIN SUBLING TAB 0.3MG 10 0 NDC CODE:68462063801 FDA P RODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 A NDA NO.:206391 THERAPEUTIC US E: -MEDICATION USED FOR HEAR T FAILURE,HIGH BLOOD PRESSURE ,AND TO TREAT AND PREVENT CHE ST PAIN FROM NOT ENOUGH BLOOD FLOW TO THE HEART COMMERC IAL & CUSTOM INVOICE NO. F224 87001626 DT. 13.12.2023 S/BIL L NO: 4019223 DT: 14/12/2024 NET WT. 14.87 KGS 02 DATA LO GGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GL ENMARK SPECIALTY S.A. SWITZER LAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND
2024-01-19 MAEU234314297 GLENMARK PHARMACEUTICALS LTD 9642.18 kg 609900 40 PALLETS 4064 CARTONS PH ARMACEUTICALS AS UNDER ACAM PROSATE CALCIUM DR TAB 333MG 1 80 NDC CODE:68462043518 FDA PRODUCT CODE NO.: 60 T C C 99 H. T. S NO.: 3004.90.92.40 ANDA NO.:202229 THERAPEUTICE USE: - FOR TREATING ALCOHOL DEPENDENCE OLMESARTAN MEDO X TAB 20MG 30 NDC CODE:684620 43730 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3004.90 .9220 ANDA NO.: 203281 THERA PEUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS , TO LOWER BLOOD PRESSURE ADAPALENE-BPO GEL PUMP 0.1/2.5 % 45GM NDC CODE:68462030147 FDA PRODUCT CODE NO.: 62 S D O 02 H. T. S NO.: 3004.90.92 .45 ANDA NO.: 208108 THERAPE UTICE USE: - USED ON THE SKIN TO TREAT ACNE TOPIRAMATE TAB 25MG 500 NDC CODE:6846201 0805 FDA PRODUCT CODE NO.: 6 1 M C A 40 H. T. S NO.: 3004 .49.00.20 ANDA NO.:077627 TH ERAPEUTICE USE: ANTICONVULSAN T OXCARBAZEPINE TAB 300MG 1 00 NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTIC E USE:-ANTI CONVULSANT AGENT TROSPIUM CL TAB 20MG 60 ND C CODE:68462046160 FDA PRODUC T CODE NO.:-61 K C A 69 H. T . S NO.: 3004.49.00.70 ANDA NO.:-91-575 THERAPEUTICE USE: - TREATMENT OF VENOUS DISEAS ES URINARY INCONTINENCE THER APY THEOPHYLLINE ER TAB 600 MG 100 NDC CODE:68462035601 FDA PRODUCT CODE NO.: 63 B C B 30 H. T. S NO.: 3004.90.92 .85 ANDA NO.: 90-355 THERAPE UTICE USE: XANTHINE BRONCHODI LATOR COMMERCIAL & CUSTOM I NVOICE NO. F22452004461 DT. 1 4.12.2023 F22452004465 DT. 15 .12.2023 F22452004468 DT. 15. 12.2023 F22452004469 DT. 15.1 2.2023 S/BILL NO: 6081506 DT 16-DEC-2023 S/BILL NO: 608149 4 DT 16-DEC-2023 S/BILL NO: 6 083781 DT 16-DEC-2023 S/BILL NO: 6081498 DT 16-DEC-2023 NE T WT. 7569.819 KGS 02 DATA L OGGERS SET TEMPERATURE : +2 0 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA
2024-01-16 MAEU234585313 GLENMARK PHARMACEUTICALS LTD 11781.81 kg 621800 42 PALLETS 3441 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 300MG 100 NDC C ODE:68462013801 FDA PRODUCT C ODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-802 THERAPEUTICE USE:-AN TI CONVULSANT AGENT OLMESA RTAN MEDOX TAB 40MG 30 NDC CO DE:68462043830 FDA PRODUCT CO DE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO.: 2032 81 THERAPEUTICE USE: - -TREA TMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSI VE AGENTS, TO LOWER BLOOD PRE SSURE DICLOFENAC SOD GEL 3% 100GM NDC CODE:68462035594 FDA PRODUCT CODE NO.:62 G C J 18 H. T. S NO.: 3004.90.92. 40 ANDA NO.:208301 THERAPEUT ICE USE: - USED FOR THE RELIE F OF JOINT PAIN OF OSTEOARTHR ITIS OLMESARTAN MEDOX TAB 4 0MG 30 NDC CODE:68462043830 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 THERAPEUTICE USE: - -TREATMENT OF HYPERT ENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS, TO L OWER BLOOD PRESSURE COMMERC IAL & CUSTOM INVOICE NO. F224 52004493 DT. 18.12.2023 F2245 2004496 DT. 18.12.2023 F22452 004506 DT. 18.12.2023 S/BILL NO: 6127407 DT 18-DEC-2023 S/ BILL NO: 6127366 DT 18-DEC-202 3 S/BILL NO: 6134120 DT 18-DE C-2023 NET WT. 9739.126 KGS 02 DATA LOGGERS SET TEMPER ATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA
2024-01-16 MAEU234505051 GLENMARK PHARMACEUTICALS LTD 344.74 kg 621800 2 PALLETS 120 CARTONS PHAR MACEUTICALS AS UNDER ACYCLO VIR OINT 5% 30GM NDC CODE:684 62074635 FDA PRODUCT CODE NO. : 62 V C J 18 H. T. S NO.: 3004.49.00.50 ANDA NO.: 20551 0 THERAPEUTICE USE: - AN ANT IVIRAL MEDICINE USED TO TREAT OR PREVENT INFECTIONS CAUSED BY CERTAIN KINDS OF VIRUSES. EXAMPLES OF THESE INFECTIONS INCLUDE HERPES AND SHINGLES COMMERCIAL & CUSTOM INVOICE NO. F22452004495 DT. 18.12.2 023 S/BILL NO: 6127376 DT 18- DEC-2023 02 DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK SP ECIALTY S.A. SWITZERLAND (GSS A) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND
2024-01-16 MAEU234512397 GLENMARK PHARMACEUTICALS LTD 2137.82 kg 300490 12 PALLETS 1067 CARTONS PH ARMACEUTICALS AS UNDER SOLI FENACIN SUCCINATE TAB 5MG 30 NDC CODE:68462038630 FDA PROD UCT CODE NO.: 61 KCA 72 H. T . S NO.: 3004 49 00 70 ANDA NO.: 209239 INDICATED FOR THE TREATMENT OF OVERACTIVE BLA DDER WITH SYMPTOMS OF URGE UR INARY INCONTINENCE, URGENCY AND URINARY FREQUENCY APREP ITANT CAP 125-80MG 3UOU NDC C ODE:68462011233 HTS NO : 3004 .90.92.40 FDA CODE : 61 T C E 32 ANDA NO : 207777 THERAPE UTICE USE : APREPITANT IS USE D WITH OTHER MEDICATIONS TO H ELP PREVENT VOMITING CAUSED BY CANCER DRUG TREATMENT NI TROGLYCERIN SUBLING TAB 0.4MG 4X25 NDC CODE:68462063945 FD A PRODUCT CODE NO.: 66 S C A 28 H. T. S NO.: 3004.90.9020 ANDA NO.:206391 THERAPEUTIC USE: -MEDICATION USED FOR H EART FAILURE,HIGH BLOOD PRESS URE,AND TO TREAT AND PREVENT CHEST PAIN FROM NOT ENOUGH BL OOD FLOW TO THE HEART COMM ERCIAL & CUSTOM INVOICE NO. F 22487001677 DT. 20.12.2023 F2 2487001680 DT. 20.12.2023 F22 487001681 DT. 20.12.2023 S/BI LL NO: 4019639 DT:21/12/2023 S/BILL NO: 4019642 DT:21/12/20 23 S/BILL NO: 4019644 DT:21/1 2/2023 NET WT.340.91 KGS 1 2 DATA LOGGERS SET TEMPERA TURE : +20 DEGREES NOTIFY P ARTY:2 GLENMARK SPECIALTY S.A . SWITZERLAND (GSSA) PLACE D U PORT 2 NEUCHATEL - 2000 SW ITZERLAND
Contact information
Search contact information on RocketReach
Other address
301 ISLAND RD NEW JERSEY MAHWAH USA- 07430 LABELER CODE : 68462:
301 ISLAND ROAD NEW JERSEY MAHWAH
301 ISLAND RD NEW JERSEY MAHWAH USA- 07430
301 ISLAND RD NEW JERSEY MAHWAH PO BOX: USA- 07430
301 ISLAND RD NEW JERSEY MAHWAH USA- 07430 LABELER CODE : 68462
301 ISLAND ROAD NEW JERSEY MAHWAH USA- 07430 LABELER CODE : 68462: